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Abstract

Human Papillomavirus Vaccination Status and Endorsement among Undergraduate
Nursing
Students: A Secondary Data Analysis
By Ashley Hollins, MSN-ED., RN, FNP-BC
May, 2019
Human papillomavirus (HPV) vaccination has immense potential to prevent
HPV-related infections but vaccination rates remain suboptimal. Nurses could potentially
increase vaccination rates by providing recommendations and addressing vaccine
concerns. As student nurses’ transition into practice, it is important to identify factors
that could influence their attitudes and uptake of the HPV vaccine; however, these factors
remain unknown.
Purpose: We proposed to: (1) identify factors associated with HPV vaccination status
and (2) to identify student nurses’ perception of parental vaccine hesitancy, preferred
counseling strategies, and factors associated with their intention to counsel parents on
HPV.
Methods: The current study was a secondary analysis of a randomized controlled trial
(NCT02600884, PI: Santa Maria). UTHealth student nurses (n=153) provided data
through a 172-item baseline Student Nurse Survey. Descriptive statistics, chi-square tests,
and independent t-tests (p < .05) were utilized to characterize the sample and to compare
responses between non-initiators, initiators, and completer groups. A logistic regression
model was developed to identify factors associated with vaccination status.
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Results: Only slightly more than half of student nurses (58%) had received at least one
dose of the HPV vaccine. Those who were older and married or living with a partner
were less likely to complete the HPV vaccine series. The most common reasons for
receiving the vaccine were: doctor’s recommendation, confidence in the HPV vaccine,
and mother’s recommendation. Conclusion: Interventions to increase vaccination rates
among student nurses should address HPV risk misperceptions among young adults and
healthcare providers to promote HPV vaccination.
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Summary of Study

Human papillomavirus (HPV) is the most common sexually transmitted infection
in the United States, with potentially serious health consequences, including anogenital
and oropharyngeal cancer (Markowitz et al., 2014). Student nurses of traditional college
age have greater risk of infection, but many remain unvaccinated (Markowitz et al.,
2014). As student nurses’ transition into practice they could potentially increase
vaccination rates by discouraging myths and providing strong vaccine endorsements
(Warner et al., 2017).
The proposal entitled, “HPV Vaccination Status and Endorsement among
Undergraduate Nursing Students” was a secondary data analysis of data from a
randomized controlled trial conducted by Dr. Diane Santa Maria, of The University of
Texas Health Science Center at Houston Cizik School of Nursing (UTHealth)
(NCT02600884). The goals of this dissertation project were to 1) to identify factors
associated with HPV vaccination status among student nurses and 2) to identify students’
perception of factors associated with parental vaccine hesitancy, intent to counsel parents
on the HPV vaccination, and preferences for counseling vaccine-hesitant parents.
The study proposal, which follows the summary, outlines the specific aims,
significance of the problem, proposed methods, and statistical analyses. The study was
approved by the Committee for the Protection of Human Subjects (CPHS) at the
University of Texas Health Science Center at Houston’s Institutional Review Board
(Appendix C). The primary study data was collected between August 2015 and May
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2018 from a purposive sample of student nurses (n=153) recruited from UTHealth
undergraduate public health nursing (PHN) clinical courses.
The manuscript outlines the analyses, results for both aims of the project, and
discussion of study findings. Appendices A-C contain supplemental information from
the studies including the conceptual framework, CPHS approval from the University of
Texas Health Science Center, and FTT+HPV Student Nurse Survey.
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Proposal
Human Papillomavirus (HPV), is the most widespread sexually transmitted
infection (STI) worldwide (Markowitz et al., 2014). An estimated 80 million Americans
are currently infected with HPV (Owusu-Edusei et al., 2013), and nearly 42,700 new
cases of HPV-associated cancers are expected to develop yearly (Satterwhite et al.,
2013). HPV, which has more than 150 types, causes nearly all cervical cancers and many
cancers of the vagina, vulva, penis, anus, rectum, and oropharynx; in addition to genital
warts and recurrent respiratory papillomatosis (de Villiers, Fauquet, Broker, Bernard, &
Zur Hausen, 2004).
The HPV vaccine is a cost-effective prevention strategy to provide protection
against associated cancers and genital warts, and yet it remains one of the most
underutilized vaccines in the United States (McRee, Gilkey, & Dempsey, 2014). The
Centers for Disease Control and Prevention (CDC) Advisory Committee on
Immunization practices (ACIP) recommends administration of the HPV vaccine to 11-to
12-year old adolescents with a “catch-up” vaccination for those aged 13- 45 years
(Allison et al., 2016; McRee, Gilkey, & Dempsey, 2014; U.S. Food and Drug
Administration, 2018). Despite the potential severity of health outcomes associated with
HPV, the national vaccination coverage rates continue to demonstrate low vaccine uptake
and completion among adolescents and young adults (Markowitz et al., 2014).
Although HPV vaccination correlates have been discovered, little is known about
the relationship between demographic factors and HPV vaccination status among student
nurses. Understanding and increasing vaccine uptake among 18-26-year-old adults is
particularly important, as these individuals are among the age group with the highest rates
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of newly acquired HPV infections yearly (Satterwhite et al., 2013). Moreover, student
nurses represent the next generation of healthcare providers and are in a position to
influence vaccine uptake through their own personal and professional health choices,
decision regarding future children and patients, and willingness to provide vaccine
counseling and endorsements. As HPV- associated cancers rates steadily rise and
vaccine uptake remains low, it is necessary to identify factors that could influence HPV
vaccine uptake among this population.
Our long-term goal is to develop useful educational interventions to address
factors that influence vaccination attitudes and behaviors that maximize HPV vaccine
endorsement among student nurses. The overall objectives of this proposal are to (1)
identify modifiable factors that may influence HPV vaccination status in student nurses
and (2) explore their perceptions of parental vaccine hesitancy, intentions to counsel, and
strategies that may assist with counseling vaccine-hesitant parents on the HPV
vaccination among student nurses. Our goal is to better understand factors that may
contribute to HPV vaccine uptake and endorsement among emerging healthcare providers
and to inform development of educational tools and strategies to address those factors to
improve suboptimal vaccination rates. The rationale for this project is that identifying
student nurses’ personal and perceived parental barriers to vaccine uptake may assist with
improving HPV vaccination rates and their counseling ability to provide a strong
endorsement of CDC recommended vaccines. To attain the overall objectives, the
following aims will be pursued:
1.

To identify factors associated with HPV vaccination status among student nurses.
RQ 1: What is the association between age, race/ethnicity, marital status,
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religion, and HPV vaccination status among student nurses?
RQ 2: What do student nurses perceive as motivational factors to
HPV vaccine uptake and completion?
2.

To identify student nurses’ perception of parental vaccine hesitancy, preferred
counseling strategies, and factors associated with intention to counsel vaccinehesitant parents on the HPV vaccination.
RQ 1: What do student nurses perceive as parental barriers to HPV vaccine
uptake?
RQ 2: What is the association between students’ HPV endorsement outcome
expectations, vaccination status, and skills satisfaction as both a parent
child communication counselor and adolescent sexual health educator
on their intention to counsel parents about the HPV vaccination?
RQ 3: What are student nurses’ perceptions of potential strategies that may
assist with counseling vaccine-hesitant parents on the HPV
vaccination?
At the completion of the proposed research, our expected outcomes are to have

determined factors associated with vaccine uptake and completion among student nurses
and to identify perceived parental barriers that may hinder their intentions to counsel
parents among student nurses. Identifying these factors may assist with addressing
discrepancy between nurses’ perception of parental barriers and barriers often reported by
parents. These results will assist in developing strategies to improve HPV vaccine uptake
among adults, provider endorsement of the HPV vaccination, and provider-patient
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communication, which in turn may influence evidence-based practices and health
interventions, ultimately increasing vaccine recommendations, uptake, and completion.
Significance
Scientific Premise
Sexually active adolescents and young adults (ages 15-24) have the highest
prevalence of new acquired HPV infections (Moscicki, 2007). Most infections are
transient and asymptomatic; however, individuals who eventually clear the virus without
developing cancer can still pass it on to others (Markowitz et al., 2014). High-risk HPV
types cause nearly all cervical cancers and many cancers of the vagina, vulva, penis,
anus, rectum, and oropharynx (de Villiers, Fauquet, Broker, Bernard, & Zur Hausen,
2004; Lowy& Schiller, 2012; Muñoz et al., 2003). Low-risk HPV types cause 90% of all
genital warts; in addition to benign or low-grade cervical cell changes and recurrent
respiratory papillomatosis (Lacey, Lowndes, & Shah, 2006).
HPV vaccines are more than 98% effective in reducing the incidence of HPV types
that are responsible for genital warts and associated cancers (Braaten & Laufer, 2008).
Despite proven benefits, HPV vaccination rates remain far below Healthy People 2020
goal of 80 percent coverage (Jain, Singleton, Montgomery, & Skalland, 2009). Of those
aged 13 - 17 years of age, only 50% of girls and 38% of boys had received all doses of
the HPV vaccine series (Walker et al., 2017). In 2016, coverage with at least one dose of
the HPV vaccine was 48.5% among females and 13.5% among males aged 19 to 26
(Lewis & Markowitz, 2018).
While coverage rates for routinely recommended vaccines continue to rise, HPV
vaccination rates have increased minimally. This may suggest that the factors
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surrounding healthcare providers, parents and young adults’ attitudes about the HPV
vaccine are different from other vaccines. Increasing vaccination coverage to 80%, could
prevent 90% or 31,200 cases of cancers caused by HPV each year (Gargano et al., 2017;
Hariri et al., 2011). Administering the HPV vaccination at the recommended age will
help to reduce risk of contracting HPV as well as infections. But for this to occur,
healthcare providers, parents, and young adults must be willing to accept the HPV
vaccine.
Nurses are often sought out by patients to assist with health-related concerns
(Johnson-Mallard et al., 2014). An essential component of nursing involves advocating
for patients by supporting causes that help to promote optimal health such as health
education and immunizations. Nurses play a central role in fostering vaccine uptake and
completion by providing strong vaccine recommendation; educating individuals and
families about when to begin the vaccine series; and by addressing concerns related to
vaccine myths, safety, and hesitancy (Gustavo da Silva Fagundes, Frota, & Silva, 2018).
Parents who changed their minds after delaying or refusing vaccination for their child
cited information or assurances from healthcare provider as the main reason (Dube et al.,
2013; Leask et al., 2008). One study revealed that the most trusted source of health
information among parents came from their local nurse or family physician; however,
few reported receiving vaccine information or advice from their healthcare provider (La
Vincente et al., 2015). A nurses’ knowledge and attitudes toward vaccination have been
cited as important determinants of their own personal vaccine uptake, intention to
promote vaccinations, and the uptake of vaccination among their patients (Dube et al.,
2013; Zhang, While, & Norman, 2010).
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Personal beliefs, perceived sexual health risk, and self-confidence to address
questions or engage in uncomfortable conversations with those who are reluctant to be
vaccinated have been strongly associated with vaccine uptake, intentions to counsel, and
recommendation practices among nurses (Duval et al., 2009; Paterson et al., 2016;
Wamai et al., 2013). Anticipated parental hesitancy, lack of preparedness for advising
patients and lack of training may play a role in nurses’ willingness to recommend
vaccination (Ildarabadi, Moonaghi, Heydari, Taghipour, & Abdollahimohammad, 2015).
Failure to discuss vaccination may result in missed clinical opportunities for receipt of
the HPV vaccination, which may lead to the development of more HPV-related cancers
each year.
Overall Scientific Premise
A nurses’ direct involvement in vaccine endorsement has been associated with
increased vaccine uptake (Miller et al., 2015). Nurses are often sought out by parents and
students for their expertise regarding the safety and efficacy of vaccinations (JohnsonMallard et al., 2014). Due to their regular contact with patients, nurses are wellpositioned to address patients’ concerns that may influence vaccine uptake and
completion among patients (Johnson-Mallard et al., 2014). Studies suggest that a nurses’
willingness to recommend vaccination may be influenced by personal knowledge and
beliefs toward HPV (Perkins & Clark, 2012; Holman et al., 2014). Vaccinated nurses
and those who express a willingness to be vaccinated are more likely to recommend HPV
vaccination to their patients (Askarian, Khazaeipour, & McLaws, 2011; Makwe &
Anorlu, 2011; Lavela et al., 2004).
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Scientific Premise for Aim #1
While the choice of whether or not to vaccinate adolescents is mainly placed upon
parents, college aged youth are often able to make vaccine decision for themselves.
Perceptions of vulnerability to HPV infection and HPV-related disease have been
strongly associated with vaccination uptake among high-risk populations (Downs et al.,
2010; Marchand, Glenn, & Bastani, 2012). Research posits vaccine acceptability may be
linked to distrust in healthcare system, cultural or fatalistic beliefs, lack of access and
utilization of healthcare; in addition to lack of provider recommendation among minority
racial and ethnic groups (Holman et al., 2014; Jeudin et al., 2014; Tsui et al., 2014).
Studies indicate that increased vaccine uptake among college students is strongly
associated with being younger age; non-Hispanic; Caucasian; being unmarried; not
practicing organized religion; receiving a doctors’ recommendations; attitudes toward
vaccination; supportive beliefs from peers and significant others; and vaccination costs
(Barnard, George, Perryman, & Wolff, 2017; Cohen & Legg, 2014; LaJoie, Kerr, Clover,
& Harper, 2018; Lefkowitz et al., 2014; Thompson et al., 2016a).
Many patients rely on their healthcare providers to assist with decisions
concerning healthcare and well-being. Provider recommendation has been cited as one of
the most influential factors in vaccine acceptability and uptake among young adults,
adolescent and parents (Kahn et al., 2007; Reiter et al., 2013a; Duncan & Newman,
2015). Thus, healthcare providers are a critical component to successful provision of the
HPV vaccine. Additionally, studies indicate that patients’ intention to vaccinate against
HPV relies heavily on their knowledge, beliefs, and attitudes toward the HPV disease and
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the vaccine; in addition to the convenience of receiving the vaccine (Gamble et al., 2010;
Holman et al., 2014).
The importance of the nurse’s role in vaccine promotion, signifies the critical
need to identify factors that contribute to vaccine uptake among the next generation of
nurses, who will play a critical role in vaccine promotion and disease prevention.
Additionally, this study may identify factors associated with vaccine uptake and
completion among young adults, as many student nurses are within this age group and
may also be undervaccinated. Research findings may provide empirical support for nurse
educators and those responsible for vaccination delivery who may want to develop new
education programs or reform vaccination training. In addition, this study will serve as
the first step in developing strategies and education tools which are critically needed to
improve provider-level vaccine intentions, vaccination practices, and completion.
At this time, to our knowledge, no investigators have reported on the factors
associated with the HPV vaccination status of student nurses. For this group of adults, it
is not too late to vaccinate against HPV. On October 5th, 2018, the U.S. Food and Drug
Administration (FDA) approved expanding the use of the Gardasil 9 HPV vaccine to
include all women and men through 45 years of age (U.S. Food and Drug Administration,
2018). Therefore, identifying these factors will inform the development of a critically
needed intervention that could improve patient and provider vaccine hesitancies, vaccine
uptake and completion rates, and create an opportunity to help prevent HPV-related
disease burdens in a broader age range. The significance of the study lies in its ability to
identify factors associated with vaccine initiation, uptake, and completion among an
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important population, who play an instrumental role in HPV vaccine promotion,
adoption, and disease prevention.
Scientific Premise for Aim #2
Nurses represent the largest group of healthcare providers, who are usually in the
age range for being at the highest risk of acquiring new HPV infections. Studies indicate
that healthcare providers in the United States generally have positive attitudes toward the
HPV vaccine (Allison et al., 2016; Hill & Okugo, 2014; Hofstetter et al., 2017; McRee,
Gilkey, & Dempsey, 2014; Perkins & Clark, 2012). Interestingly, the majority of the
studies report a high percentage of providers who do not recommend the vaccine for
adolescent in the recommended age group (Allison et al., 2016; Hofstetter et al., 2017;
McRee, Gilkey, & Dempsey, 2014; Perkins & Clark, 2012; Soon et al., 2015; Tom et al.,
2016).
Healthcare providers often cite parental beliefs, financial concerns, and lack of
time as barriers to vaccine promotion (McRee, Gilkey, & Dempsey, 2014; Tom et al.,
2016). In terms of reasons for HPV vaccine delay or refusal, most providers
overwhelmingly agreed that factors that contributed to parents’ decisions included: belief
that his/her child is not at risk, belief that their child is not sexually active, lack of
parental education/understanding of HPV, as well as parental reluctance to discuss sex
with their child (McRee, Gilkey, & Dempsey, 2014; Tom et al., 2016). Conversely, lack
of provider endorsement was cited as the leading barrier to vaccination uptake among
parents (Dorell, Yankey, & Strasser, 2011; Reiter, Katz, & Paskett, 2013b). Healthcare
providers’ perceptions of sexual health risk, parental vaccine hesitancy, importance of
vaccination and counseling have been well documented as barriers to HPV counseling
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intentions and vaccine uptake (Dube et al., 2013; McRee, Gilkey, & Dempsey, 2014).
Barriers to vaccination and low vaccine coverage rates, point to the critical need to better
understand providers’ attitudes toward HPV vaccination, strategies to assist with vaccine
endorsement, and barriers to HPV vaccination uptake from the point of view of student
nurses.
In the case of HPV recommendation, a healthcare providers’ perceived ideas of
patient benefits and health risk, perceptions of parental barriers, personal beliefs, and past
encounters with patients may influence their decisions to provide vaccine counseling
(Hill & Okugo, 2014; Hofstetter et al., 2017; McRee, Gilkey, & Dempsey, 2014; Perkins
& Clark, 2012; Soon et al., 2015). In addition, negative experiences with vaccine-hesitant
parents may discourage providers from routinely recommending the HPV vaccine
(McRee, Gilkey, & Dempsey, 2014). Importantly, these findings are concerning given
that recent research suggest that parental concerns in regard to the HPV vaccine are
overestimated by healthcare providers (Healy, Montesinos, & Middleman, 2014). A
recent study reported that most healthcare providers rarely ask questions to explore
parents’ reasons for vaccine delay or refusal (McRee, Gilkey, & Dempsey, 2014).
Furthermore, the study concluded that providers with low confidence in their ability to
address parental concerns were less likely to recommend HPV vaccination according to
national guidelines (McRee, Gilkey, & Dempsey, 2014).
Low self-confidence, lack of preparedness, and lack of training were found to be
important barriers that impact vaccine recommendations among nurses (Paterson et
al.,2016). Many nurses are in need of additional education to address parental vaccine
hesitancy. As student nurses transition into the role of a professional nurse, it is vital that
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we understand what factors may influence their intentions to counsel and recommend the
HPV vaccine.
At this time, to our knowledge, there are no published studies that have reported
on students’ perception of parental vaccine hesitancy, preferred counseling strategies,
factors associated with their intention to counsel parents on the HPV vaccination, or
student nurses' intentions to vaccinate themselves. Identifying these factors would likely
be a critical intervention that could improve vaccine hesitancy, counseling intentions, and
overall vaccination rates. Effective and efficient ways of addressing perceived barriers
and improving providers’ self- efficacy are critically needed as these factors have been
documented as key barriers to vaccine recommendation, uptake, and completion. The
significance of this study lies in its ability to identify provider-level barriers associated
with HPV vaccine recommendation. The study findings may also assist with designing
and evaluating vaccine training programs and communication tools that may assist
healthcare providers with addressing vaccine questions and difficult conversations with
vaccine-hesitant parents.
Theoretical Framework
The Theory of Planned Behavior (TPB) will provide the framework for
examining how student nurses’ beliefs influence their intention to receive the HPV
vaccine and their intentions to counsel parents on the HPV vaccination (Figure 1). The
TPB identifies four concepts that can be used to explain factors that indirectly and
directly influence an individual’s intention and action toward vaccination. For the
purpose of this study, contributing factors, beliefs, perception/attitudes, behavioral
intentions, and behavioral outcomes will be examined among student nurses.
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Nurses are a key source of information to parents, adolescents, and young adults.
Many parents rely on nurses to assist with decisions concerning their adolescent’s health
and well-being. Evidence suggests that improving provider-parent communication
through participatory (vs presumptive) communication formats to initiate vaccine
recommendations may influence parent’s likelihood to accept vaccination (Opel et al.,
2013; Opel et al., 2015). In addition, studies suggest that healthcare provider willingness
to recommend vaccination may be influenced by personal knowledge and beliefs toward
HPV (Perkins & Clark, 2012; Holman et al., 2014). Thus, to improve vaccination rates of
patients, it is vital that we fully understand factors associated HPV vaccination status and
intentions to counsel among student nurses. The application of the TPB will assist in
understanding the causal and correlational relationship among social influences, attitudes
and beliefs, and behavior intentions/action toward vaccine recommendation and uptake.
Innovation
The research proposed in this proposal is innovative, because it focuses on
identifying student nurses’ perspectives on factors associated with HPV vaccine uptake
and completion, perceived parental barriers to vaccine recommendation, and tools and
strategies to assist with counseling parents on the HPV vaccination. While many studies
have identified that provider-perceived parental barriers to vaccination exist, exploring
factors that may contribute to vaccine uptake among student nurses is expected to allow
us to overcome some current limitations of vaccine delivery. Thus, thereby opening new
horizons for more effective strategies, vaccination training programs, and screening tools
to facilitate better communication and self-efficacy to address vaccine hesitancy among
young adults, healthcare providers, and parents.
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Approach
Methods
Research Design, Sample and Setting
A secondary data analysis will be conducted from a randomized controlled trial
(RCT) titled, “Efficacy Trial of a Brief Parent Based Adolescent Sexual Health
Intervention” funded by the National Institute of Child Health and Human Development
(NIH) conducted by the Principal investigator (PI) Dr. Diane Santa Maria, of The
University of Texas Health Science Center at Houston Cizik School of Nursing
(UTHealth) (NCT02600884). The study was a community-based RCT that used parentchild dyads (n= 513) from predominantly minority communities in the greater Houston
area to determine the impact of a student nurse-as-educator program, Families Talking
Together Plus (FTT + HPV), on minority parent and adolescent outcomes.
A purposive sample of student nurses (n=153) were recruited from UTHealth
undergraduate public health nursing (PHN) clinical courses (15 sections containing
approximately 10 students each). Students were deemed eligible for the study if: they
were currently enrolled in the PHN clinical course and expressed willingness to complete
baseline and end of semester anonymous surveys. Using a quasi-experimental design,
students were non-randomly assigned to the intervention or control arm. The student
nurses in the intervention arm (n=103) attended curriculum training of Families Talking
Together (FTT) with an added HPV component (FTT+ HPV). FTT is a parent-based
sexual health intervention to prevent and/or reduce sexual risk behavior by promoting
effective communication skills, building parent-adolescent relationships and helping
parents to develop successful monitoring strategies. Students in the control arm
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completed a public health nursing clinical rotation that did not cover adolescent sexual
health topics. Then the student nurses delivered brief face-to-face sessions, a manual, and
booster calls to parents of youth 11- 14 years old as part of their community clinical
experience.
The primary aim of this secondary analysis is to identify factors associated with
the HPV vaccination status among student nurses and to identify students’ perception of
factors associated with parental vaccine hesitancy, intent to provide HPV vaccination
counseling to parents, and preferences for counseling vaccine-hesitant parents using
baseline survey data from the total sample (n=153). The initial study has been approved
by the IRB. A request for approval to conduct this secondary analysis will be made. It is
anticipated it will take up to 6 months to conduct the analysis and write the scientific
manuscript.
Data Collection
For the purpose of this research and in order to achieve the objectives, a
secondary analysis will be conducted. The primary study data was collected between
August 2015 and May 2018. Before implementation of the intervention, a baseline
investigator developed the Student Nurse Survey that was collected on 153 volunteer
student nurses who attended UTHealth via tablet or internet hyperlink.
Sample Size and Power
For Aim 1.2, the power analysis for this secondary data analysis was conducted in
G-POWER using an alpha of 0.05 and a sample size (n=155) for a two-tailed test. Based
on this sample size, a logistic regression model will have 80% power when the effect size
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is an odds ratio (OR) = .54. This equates to a 46% reduction in the odds of vaccine uptake
for every one-point increase in age.
For Aim 2.2, the power analysis for this secondary data analysis was conducted
in G-POWER using an alpha of 0.05 and a sample size (n=153) for a two-tailed test.
Based on this sample size, a spearman’s rho correlation model will have 80% power
when the effect size is 0.22.
Instruments
The initial research team developed a self-administered survey (Appendix B).
Survey items were drawn from measures used in prior published studies of HPV
vaccination uptake and sexual health. The questionnaire was divided into three sections:
(1) demographic characteristics, (2) outcome expectations and health-related beliefs, and
(3) behavioral intentions. The first section consisted of demographic characteristics (11
items), in addition to the Sex Education Confidence Scale (SECS) (22 items).
Demographics factors assessed included age, race/ethnicity, primary language, education
level, marital status, religion, and the importance of religion to participant. The second
section consisted of health-related beliefs investigating perceived stress (3 items, Cohen,
Kamarak, & Mermelstein, 1994), safety of vaccination (1 item, Marlow, Waller &
Wardle, 2007), parent-child communication about sexual health, perceived adolescent
sexual health risk, sexual health parent-child communication outcome expectancies, skills
satisfaction for parent sexual health counselor, skills satisfaction as adolescent sexual
health educator, parental monitoring, and intentions to counsel parents on the HPV
vaccination developed by Guilamo‐Ramos et al. (2011) for use with parents and
adolescents (45 items). HPV endorsement intentions and outcomes, experience providing
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HPV vaccination counseling to parents, parents reactions to HPV vaccination
recommendation, contributing factors to parental or refusal of HPV vaccination, actions
taken when counseling HPV-vaccine hesitant parents, and helpfulness of tools when
counseling HPV-vaccine hesitant parents were assessed using survey items developed by
McRee, Gilkey, & Dempsey (2014) (57 items). In addition, likelihood of receiving HPV
vaccination along with determining factors for HPV vaccine receipt, completion, or
incompletion were assessed using three questions developed by Kessel et al. (2012) (4
items). The third section consisted of behavioral intentions investigating HPV initiation,
continuation, and completion utilizing three questions developed by Widdice et al. (2011)
for use with female patients (4items).
A 5-point Likert scale was used for questions regarding beliefs about sexual
health, intentions to counsel, HPV, and HPV endorsement outcomes expectancies, with
response options ranging from “strongly disagree” to “strongly agree”. A 5-point Likert
scale was also used for questions about skills satisfaction, HPV endorsement, perceived
stress, and experience providing HPV counseling. The questions regarding HPV
vaccination initiation, continuation, and completion used dichotomized yes or no
responses. The remaining questions regarding the HPV vaccination series used a 9-point
Likert scale with answer choices ranging from (1) The doctor's recommendation, (2) it
became common practice/It has been standard for years/I was comfortable with
recommendation, (3) I knew enough about HPV disease and the vaccine, (4) I became
sexually active, (5) My insurance covered the cost/No cost concerns, (6) I had enough
information about vaccine safety, (7) It was convenient for me to get vaccinated/I found
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the time to do so, (8) Other, please specify, and (9) Don't know. The survey was
designed to be completed within 30 minutes on average.
For this secondary data analysis, the following scales and items will be used from
the main questionnaire: demographic information (5 items: age, race/ethnicity, marital
status, religion, importance of religion), HPV Endorsement Outcomes Expectancies Scale
(8 items, HPV Endorsement Outcomes Expectancies Scale, McRee, Gilkey, & Dempsey,
2014), Outcome Expectancies (9 items, Sexual Health Parent-Child Communication
Outcome Expectancies, Guilamo-Ramos et al., 2011b), Skills Satisfaction (12 items,
Skills Satisfaction as a Communication Counselor and Sexual Health Educator, GuilamoRamos et al., 2011a), Intentions (2 items, Intentions to Counsel Parents on the HPV
vaccination, Guilamo-Ramos et al., 2011b), Perceived Parental Barriers (13 items,
Contributing Factors to Parental Delay or Refusal of HPV Vaccination, McRee, Gilkey,
& Dempsey, 2014), Tools and Strategies for Counseling (8 items, Helpfulness of Tools
when Counseling, McRee, Gilkey, & Dempsey, 2014), HPV vaccination initiation (1
item, HPV vaccination initiation, Widdice et al., 2011), HPV vaccination continuation (1
item, HPV vaccination continuation, Widdice et al., 2011), HPV vaccination completion
(1 item, HPV vaccination completion, Widdice et al., 2011), factors for receiving HPV
vaccination (1 item, factors for receiving HPV vaccination, Kessel et al., 2012), factors
for determining factor for completing HPV vaccination (1 item, determining factor for
completing HPV vaccination, Kessel et al., 2012), and reasons for incompletion of HPV
vaccination series (reasons for incompletion of HPV vaccination series, Kessel et al.,
2012).
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Factors related to Student Nurses’ HPV Vaccination Status
Factors associated with HPV vaccination were measured using 3 items developed
from Kessel et al. (2012). Students were asked, “What was the most important factor that
determined when you received the HPV shots?”, with one possible response of: (1) The
doctor's recommendation; (2) It became common practice/It has been standard for years/I
was comfortable with recommendation; (3) I knew enough about HPV disease and the
vaccine; (4) I became sexually active; (5) My insurance covered the cost/No cost
concerns; (6) I had enough information about vaccine safety; (7) It was convenient for me
to get vaccinated/I found the time to do so; (8) Other, please specify; and (9) Don't know.
Students were then asked, “What is the most important factor that will determine when
you will complete the HPV vaccination series?” with one possible response of (1) The
doctor's recommendation; (2) If it becomes common practice/Been standard for
years/Comfortable with recommendation; (3) When I know enough about HPV disease
and the vaccine; (4) Becoming sexually active; (5) Insurance covering the cost/No cost
concerns; (6) Having enough information about vaccine safety; (7) If it is convenient for
me to get vaccinated/If I find the time to do so; (8) Other, please specify; and (9) Don't
know. Lastly, students were asked, “What is main reason you will not/have completed the
HPV series in the next 12 months?”, with one possible response of: (1) My provider did
not recommend it; (2) The vaccine is not available in provider's office; (3) I did not know
about the vaccine/I did not know the vaccine was recommended for me; (4) I do not
believe the vaccine is needed or necessary; (5) The school does not require; (6) I have
safety concerns about it; (7) I am uninsured/My insurance does not fully cover shots/The
insurance co-pay or other costs are too high (i.e., administration fees and/or office visit
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charges); (8) The shot could be painful; (9) I have had difficulty making or getting an
appointment/I have had transportation problems; (10) I intend to complete the HPV series
but have not yet/Already planned; (11) I am not sexually active; (12)Other, please
specify ; and (13) Don't know.
Factors related to Student Nurses’ Intention to Counsel
Sexual Health Parent Child Communication Outcome Expectancies were assessed
using nine items developed by Guilamo-Ramos et al. (2011a) using a 5-point Likert
scale. Students were asked about the barriers and facilitators to parent child
communication with statements such as “I don’t know what to say to parents about how
to talk with youth about sex”, “I’m too embarrassed to talk to parents about how to talk
with youth about sex”, and “Talking to youth about sex won’t make a difference”, and
“Talking to youth about sex will lead to them having sex.” Response options included
“strongly disagree”, “moderately disagree” “neither agree nor disagree”, “moderately
agree” and “strongly agree”.
Skills Satisfaction was assessed using eight items developed by Guilamo-Ramos
et al. (2011a). Students were asked to rate their level of satisfaction as both a parent
communication counselor and adolescent health educator. Students responded to items
such as, “At this moment in time how satisfied do you feel with the amount of control
you have over being able to counsel a parent on how to talk with youth about sex?” and
“At this moment in time, how satisfied do you feel with your ability to discuss prevention
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of sexually transmitted infections (STIs)?” Responses were coded on a 5-point Likert
scale (1= Not at all satisfied to 5= very satisfied).
HPV Endorsement Outcomes Expectancies Scale was used to measured students’
outcome expectations when counseling parents about HPV vaccination utilizing survey
items developed from McRee, Gilkey, & Dempsey (2014). Students were asked, “When
parents wish to delay or refuse HPV vaccination, there is not much I can say to change
their minds?” and I am confident that I can address parental HPV vaccine concerns about
adolescent sexual activity?” Responses were coded on a 5-point Likert scale (1= Strongly
agree to 5 = I have no experience with this).
Perceived Parental Barriers Scale were used to measured students’ opinions on
factors associated with parental vaccine delay or refusal utilizing survey items developed
by McRee, Gilkey, & Dempsey (2014). Students were asked a series of 13 items related
to their perception of parental barriers to HPV vaccine uptake. Specifically, students were
asked, “Based on your experience in the past year, how much do each of the following
contribute to parents' decisions to delay or refuse HPV vaccination?” Students responded
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to items such as “Belief that HPV is not severe enough to warrant vaccination.”
Responses ranged from 1 (not at all) to 4 (a lot).
Helpfulness of tools was measured using 8 investigator developed items from
McRee, Gilkey, & Dempsey (2014). Students were asked, “How much would the
following strategies and tools help you when counseling parents who are hesitant to get
HPV vaccine for their adolescent children?” An example of an item is “Providing
information about HPV vaccine to parents before the clinical visit.” Responses were on a
4 –point Likert scale ranging from 1 (not at all) to 4 (a lot).
Students’ intention to counsel parents on HPV vaccination were assessed with
two items developed by Guilamo-Ramos et al. (2011b). Students were asked to respond
to the following statements, “I plan to counsel parents about the importance of
vaccinating youth against HPV.” and “I plan to counsel youth about the importance of
getting the HPV vaccine at the recommended age.” Responses were coded on a 5-point
Likert scale (1= Strongly disagree to 5 = strongly agree).
Outcome Variables
The primary outcome measures for the study is HPV vaccination status.
Vaccination status including both uptake/initiation and series completion will be assessed
through students’ self -report. HPV vaccine uptake was defined as having one or two
doses of the HPV vaccine. HPV vaccine uptake was measured using two investigator
developed items from Widdice et al. (2011). Students were asked to respond to the
following questions: (1) Did you receive dose 1 of the three dose HPV series? and (2)
“Did you receive dose 2 of the three dose HPV series?”. Responses were coded 1 (yes)
and 2 (no).
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The study’s secondary outcome variable was HPV vaccine completion. Defined
as having all three doses of the HPV vaccine series. HPV vaccine completion was
measured using one investigator developed question from Widdice et al. (2011). Students
were asked to respond to the following question: Did you receive dose 3 of the three dose
HPV series? Responses were coded 1 (yes) and 2 (no). Students who obtained all three
doses of the vaccine will be included in the “Vaccine Completers” category, whereas
students who obtained < three doses were included in the “Vaccine Initiator” category.
Non-initiators will be defined as students who had not received any dose of the HPV
vaccine series.
Specific Aim 1: To identify factors associated with HPV vaccination status among
student nurses.
Introduction
Nurses are at the frontline to educate patients, families, and communities about
vaccine- preventable diseases. Research has shown that shifting vaccine promotion to
nurses is an effective strategy that promotes vaccination, influences vaccine uptake and
reduce the number of exemptions among families when compared with other healthcare
providers (Chan et al., 2011, Salmon et al., 2004). However, factors that may influence
vaccination status within this population have not been explored. The objective for this
aim is to gain a better understanding of factors influencing vaccination uptake among
student nurses by addressing the following research questions:
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RQ 1: What is the association between age, race/ethnicity, marital status,
religion, and HPV vaccine uptake and completion among student
nurses?
RQ 2: What do student nurses perceive as motivational factors to HPV
vaccine uptake and completion?
The rationale for this aim is that its successful completion is likely to contribute
more insight on factors influencing HPV vaccine intent and uptake among student nurses,
who are transitioning into the nurse role, where they will have the opportunity to promote
the HPV vaccination and reduce missed opportunities for HPV prevention. Upon
completion of the aim, it is our expectation that we will have identified critical factors
that influenced vaccine uptake among student nurses.
Data analysis
The analysis of this secondary data will be conducted using baseline FTT + HPV
student survey data to assess demographic information and factors associated with HPV
vaccination status among student nurses. All of the statistical analyses will be done using
SPSS for Mac 25 software (Statistical Package for Social Sciences, IL, USA). We expect
missing data to be minimal. Obvious errors will be corrected; those that cannot be
corrected will be set to missing and replaced using average imputation (i.e. using the
average value of the responses from the other participants to fill in the missing value
(Fox‐Wasylyshyn & El‐Masri, 2005).
Analysis for Aim 1.1-1.2 will be based on descriptive statistics. Descriptive
statistics will be calculated for the correlates: age, race/ethnicity, marital status, religion,
and factors affecting HPV vaccination status (doctor's recommendation, it became
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common practice/It has been standard for years/I was comfortable with recommendation,
I know enough about HPV disease and the vaccine, I became sexually active, My
insurance covered the cost/No cost concerns, I had enough information about vaccine
safety, it was convenient for me to get vaccinated/I found the time to do so, Other, please
specify:, and don't know), across the total sample by the outcome variable (vaccination
status). For descriptive analysis, mean, range, standard deviation (age), and percentage
for categorical variables will be calculated. Frequency tables will be created to
summarize demographic variables, including age, race/ethnicity, religion, importance of
religion, current marital status, and whether participants had received any dose of HPV
vaccination. Chi-square test will be used to test association between age, race/ethnicity,
religion, importance of religion, marital status, and whether participants had received any
dose of HPV vaccination. Statistical significance will be assessed by two-tailed tests with
 level of 0.05.
Data from Aim 1.1 will then be analyzed by multivariable logistic regression to
identify the associations between correlates (age, race/ethnicity, marital status, religion,
importance of religion) and vaccination status. Bivariate analyses with p-value  0.05
will be used criterion to select variables for multivariable analyses. Results of the logistic
regression will be presented by the odds ratios (OR) and associated 95% confidence
intervals (CI).
Expected Outcome
In terms of scientific contribution, the expected results of aim 1, will seek to
understand factors associated with HPV vaccination status from a student perspective.
Acknowledging barriers to HPV vaccination has the potential to inform educators and
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health promoters in designing strategies specific to college students and future healthcare
providers. The results of the study will aid in the advancement of theoretical
understanding of factors that may influence vaccine initiation, uptake, and completion of
the three-dose HPV vaccine series in young adult healthcare providers, which is relevant
to disease promotion and prevention. The study may increase our understanding about the
factors associated with vaccine uptake, which in turn, may allow clinicians, researchers,
and policy makers to develop multilevel interventions to improve vaccine uptake. In
addition, this study may assist with development of strategies to improve HPV vaccine
series completion and practices recommendations among young healthcare providers.
H1. There is a relationship between age, race/ethnicity, marital status, religion,
and HPV vaccine uptake among student nurses.
Specific Aim 2: To identify students’ perception of factors associated with parental
vaccine hesitancy, intent to provide sexual health and HPV counseling to parents,
and preferences for counseling.
Introduction
Healthcare providers, parents, and adolescents are critical components in the
successful provision of the HPV vaccine. Nurses serve as one of the main sources of
information to parents and adolescents. Families with children rely on nurses for
counseling and guidance regarding their health and wellbeing (Rosen, Ashwood, &
Richardson, 2016). Evidence suggests that effective communication and vaccine delivery
by healthcare provider may increase vaccine acceptance among parents (Opel et al.,
2015). However, studies have found that perceived vaccine hesitancy among nurse may
hinder strong vaccine recommendation (Dube et al., 2013; McRee, Gilkey, & Dempsey,
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2014). Thus, it is important to identify factors that may influence provider intention to
recommend vaccination as this has been associated with parental vaccine uptake. The
objective for this aim is to gain a better understanding of students’ perception of factors
associated with parental vaccine hesitancy, intent to provide HPV vaccination counseling,
and preferences for counseling parents using the following research questions:
RQ 1: What do student nurses perceive as parental barriers to HPV vaccine
uptake?
RQ 2: What is the association between students’ HPV endorsement outcome
expectations, vaccination status, skills satisfaction, and intention to
counsel parents about the HPV vaccination?
RQ 3: What are student nurses’ perceptions of potential strategies that may
assist with counseling vaccine-hesitant parents?
The rationale for this aim is that it may contribute more insight into how
provider-focused communication can best be promoted. Equally, it is important to
identify and address perceived-parental vaccine hesitancy that influence nurses’ intention
to counsel parents. Upon completion of the aim, it is our expectation that we will have
identified critical factors that influenced perceived-parental HPV barriers, intentions to
provide HPV vaccination counseling, and preferences for counseling vaccine-hesitant
parents.
Data analysis
Statistical analyses will be performed using SPSS for Windows 25 software
(Statistical Package for Social Sciences, IL, USA). We expect missing data to be
minimal. Obvious errors will be corrected; those that cannot be corrected will be set to
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missing and replaced using average imputation (i.e. using the average value of the
responses from the other participants to fill in the missing value (Fox‐Wasylyshyn & El‐
Masri, 2005).
Analysis for Aim 2.1-2.3 will be based on descriptive statistics. Descriptive
statistics will be calculated for correlates (perceived reasons for delay or refusal, potential
strategies for counseling, intentions to counsel, HPV endorsement outcome expectations,
and skills satisfaction) across the total sample by the outcome variable (HPV vaccination
status). For descriptive analysis, frequencies, mean, and percentages will be calculated.
Frequency tables will be created to summarize correlate variables of perceived reasons
for delay or refusal, potential strategies for counseling, skills satisfaction, HPV
endorsement outcome expectations, intention to counsel parents on HPV vaccination.
Data from Aim 2.2-2.3 will be analyzed by Independent Sample t test to
determine the associations between categorial data (HPV endorsement outcome
expectations, vaccination status, skills satisfaction) and the Mann-Whitney U test for
ordinal, discrete, and continuous data (intention to counsel parents on the HPV
vaccination) among groups (non-initiators vs initiators and initiators vs completers).
Statistical significance will be assessed by two-tailed tests with  level of 0.05.
Expected Outcomes
The expected results of this aim will aid in the advancement of theoretical
understanding of factors that may alter students’ intention to counsel parents on the HPV
vaccination. The results of the study may offer insights on how student nurses perceive
parental vaccine hesitancy and their role as health educators. In addition, information
learned may assist with development of educational tools to improve HPV knowledge,
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education, and support nurses’ self-efficacy to disseminate HPV information to parents.
This analysis may assist with addressing parental concerns and help to promote HPV
vaccine recommendations in accordance with national guidelines.
H1. There is an association between students’ HPV endorsement outcome
expectations, vaccination status, skills satisfaction, sexual health parent child
communication outcome expectations, and intention to counsel parents on the
HPV vaccination.
Table 1
Timeline
TIMETABLE
AIMS/TASKS
Aug
Sept
01
02
Specific Aim
#1
Benchmark


#1.1
Meet with
committee to
discuss project
goals
Benchmark
#1.2
Literature
Review
Benchmark
#1.3
Research
Questions
Finalized









Oct
03

Nov
04









Dec
05


Jan
06

Feb
07
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Benchmark
#1.4



Meet with
dissertation
committee for
proposal
defense
Benchmark
#1.5
Obtain IRB
approval from
CPHS
Benchmark
#1.6















Data
Management
and cleaning
Benchmark #1.
7
Quantitative
analysis of
survey
Benchmark
#1.8







Documentation
of results
Specific Aim
#2
Benchmark #
2.1
Meet with
committee to
discuss project
goals
Benchmark #
2.2
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Literature
Review
Benchmark #
2.3
Research
Questions
Finalized
Benchmark #
2.4









Meet with
dissertation
committee for
proposal
defense
Benchmark #
2.5
Obtain IRB
approval from
CPHS
Benchmark #
2.6













Data
Management
and Cleaning
Benchmark #
2. 7
Quantitative
analysis of
survey
Benchmark #
2.8



Documentation
of results

Potential Problems and Alternative Strategies
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Potential limitations of the study include the use of previously collected data
which resulted in a lack of control over data collection. Participants were recruited using
a purposive sample of student nurses from one Bachelor of Science Nursing school in an
urban area which may limit the generalizability of findings. In addition, the sample may
not represent overall HPV vaccine uptake and completion rates among student nurses.
Second, it is possible that those students who were most interested in parent-child sexual
health may have been more likely to participate resulting in potential selection bias.
Lastly, the use of a self-reported questionnaire may over- or underestimate responses
since students may answer in a socially acceptable manner.
Protection of Human Subjects
Institutional Review Board (IRB) approval for the primary study is attached as
Appendix C. A separate IRB form will be submitted to The University of Texas Health
Science Center at Houston IRB for an expedited review, as all of the data for this
secondary analysis was completely de-identified. There is low risk involved in this study
for the research participants. Data will be stored on a secure, password protected flash
memory external device, stored in a locked file cabinet, and locked office when not in
use. All necessary firewall and password protection will be implemented to limit access
to and ensure confidentiality of data. The data will be managed by the PI using a secure
database, computer, and locked storage file cabinet at the UTHealth Cizik School of
Nursing.
Future Directions
This study will seek to understand factors associated with HPV vaccine uptake,
provider-perceived parental vaccine hesitancy, counseling strategies, and intentions to
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counsel from a nursing perspective. The study will provide insight into factors associated
with HPV vaccine uptake and completion among young adult healthcare providers.
Findings from this study may guide educational interventions to improve vaccine
training, uptake and completion. In addition, the study findings may provide a better
understanding of perceived adult health risk in this population which may inform the
development of strategies to increase awareness, HPV vaccine recommendation, uptake
and completion. The study findings may provide implications for interventions targeted
toward provider and parental vaccination concerns which may increase vaccine uptake.
This research may guide development of strategies, vaccination training programs and
screening tools to facilitate better communication and self-efficacy to address
vaccine hesitancy among young adults, healthcare providers and parents.
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Figure 1. The Theory of Planned Behavior (TPB)
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Introduction
Human papillomavirus (HPV) infection is the most prevalent sexually transmitted
infection (STI) (Markowitz et al., 2014), with approximatively 79 million people
currently infected (Owusu-Edusei et al., 2013). An estimated 20 million new HPV
infections will occur yearly with nearly half of these among persons aged 15–24
(Satterwhite et al., 2013). Although most infections are transient and asymptomatic;
persistent infection with high risk HPV types may result in cancers of the cervix, vagina,
vulva, penis, anus, rectum, and oropharynx; in addition to genital warts and recurrent
respiratory papillomatosis (Markowitz et al., 2014). HPV- associated cancers have
drastically increased, contributing to about 43,000 cases annually in both men and
women (Centers for Disease Control and Prevention [CDC], 2018a).

Sexually active adolescents and young adults have the highest prevalence of HPV
infection with 50 - 80% of cases occurring within 2-3 years of sexual debut (Moscicki,
2007). The Advisory Committee on Immunization practices (ACIP) recommends
administration of the HPV vaccine to 11-to 12-year old adolescents with a “catch-up”
vaccination for those aged 13-26 years (U.S. Food and Drug Administration, 2018). The
HPV vaccine is a cost-effective prevention strategy to provide protection against HPVrelated health burdens; however, it remains one of the most underutilized recommended
vaccines (McRee, Gilkey, & Dempsey, 2014).
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Background

While HPV affects individuals of all ages, college students are at substantially
greater risk than older adults of developing HPV-related disease, yet many remain
unvaccinated (Markowitz et al., 2014). In 2016, coverage with at least one dose of the
HPV vaccine was 48.5% among women and 13.5% among men aged 19 to 26 (Lewis &
Markowitz, 2018). Studies indicate that vaccine uptake among college students is
strongly associated with being younger age (LaJoie, Kerr, Clover, & Harper, 2018), nonHispanic (Lefkowitz et al., 2014), Caucasian (LaJoie, Kerr, Clover, & Harper, 2018),
being unmarried (Thompson et al., 2016a), and not practicing organized religion
(Lefkowitz et al., 2014). Past studies have shown that receiving a doctors’
recommendation (Barnard, George, Perryman, & Wolff, 2017), supportive beliefs from
peers and significant others regarding the HPV vaccine (LaJoie, Kerr, Clover, & Harper,
2018), and low vaccination costs (Cohen & Legg, 2014) are key determinants in vaccine
uptake among college students.
College students represent an important population for HPV vaccination as these
individuals are among the age group with the highest prevalence of HPV infections
(Moscicki, 2007) and are a priority group for HPV catch-up vaccinations (Sharma &
Nahar, 2017). Existing research among 18 to 26 years old adults has focused on
investigating the determinants of vaccine uptake, however, the primary focus has been on
HPV-vaccine knowledge, attitudes and beliefs, social approval, provider
recommendation, and young women (Marchand et al., 2013). Since HPV vaccination
recommendations were established, few studies have examined factors associated with
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HPV vaccination status among college students and no research to date on HPV vaccine
uptake has focused specifically on student nurses.
Student nurses, as future professionals in the healthcare system, will take part in
providing vaccine education, addressing parental concerns, and providing strong vaccine
endorsements. Research has shown that shifting vaccine promotion to nurses is an
effective strategy that promotes vaccination and influences vaccine uptake among
families (Chan et al., 2011, Salmon et al., 2004). Studies suggest that vaccinated nurses
and those who express a willingness to be vaccinated are more likely to recommend HPV
vaccinations to their patients (Askarian, Khazaeipour, & McLaws, 2011; Makwe &
Anorlu, 2011). Identifying factors associated with HPV vaccine uptake may assist with
understanding and improving student nurses’ personal HPV vaccine uptake and
completion, as well as their intention to counsel and provide a strong HPV vaccine
endorsement to parents, adolescents, and adult patients.
Conceptual Framework
The Theory of Planned Behavior (TPB) posits that an individual’s intention is a
direct antecedent to behavior. The TPB describes how an individual’s intention is derived
from their attitudes toward performing the behavior, perceptions about whether
significant others think they should engage in the behavior (subjective norms), and their
perception of the ease or difficulty of performing the behavior (perceived behavioral
control). This research study applied the TPB in an effort to identify factors that
influence student nurses’ intention to receive and complete the HPV vaccine, as well as
their intention to counsel parents on the HPV vaccination. Figure 1 presents the
conceptual framework that framed this study.
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Aims
The primary aim of this study was to identify factors associated with the HPV
vaccination status among student nurses. A secondary aim of the study was to identify
student nurses’ perception of parental vaccine hesitancy, preferred counseling strategies,
and to identify factors associated with their intention to counsel parents. Additionally, the
study sought to identify factors associated with the student nurses’ personal vaccine noninitiation, initiation, and completion. To accomplish these aims, we assessed HPV
vaccination status (non-initiation, initiation, and completion) among student nurses. We
also assessed potential correlates of vaccination including demographic factors (age,
race/ethnicity, marital status, religion) and factors associated with vaccine non-initiation,
initiation, and completion in a diverse sample of student nurses recruited from a large
urban nursing school in the southwestern U.S.
Methods
The data from this study is a subset of data from a larger NIH-funded randomized
controlled trial titled, “Efficacy Trial of a Brief Parent Based Adolescent Sexual Health
Intervention” (NCT02600884). In the parent study, student nurses were recruited from an
undergraduate public health nursing course between August 2015 and May 2018. The
primary aim of the parent study was to evaluate an enhanced version of Families Talking
Together (FTT), a parent-based adolescent sexual health intervention with additional
modules on HPV and adolescent vaccinations (herein called FTT+HPV) using student
nurses as sexual health educators. In that study, student nurses delivered the FTT+HPV
intervention to parents of 11-14-year old youth. For the purpose of this study, baseline
student nurse data was used to avoid intervention effects from the training program.
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Ethics and Participants Recruitment
The University Institutional Review Board approved the study protocol. Students
were deemed eligible for the study if: they were currently enrolled in an undergraduate
public health nursing clinical course and expressed willingness to complete baseline and
end of semester surveys. The research team recruited participants in person with
information sessions provided during regularly scheduled classes. Interested students
self-selected to participate in the study and were then trained to become interventionists
for the program.
Data Collection
After providing written informed consent, participants were assigned study IDs.
Participants completed a pre-and post-intervention web-based survey on a computer or
tablet prior to the intervention and 6 months post intervention. The survey used skip logic
to administer only relevant questions based on participants’ response. The baseline
survey took approximately 30 minutes to complete and assessed demographics such as
age, race/ethnicity, marital status, religion, HPV vaccination status, HPV endorsement
outcome expectancies, skills satisfaction and intentions to counsel parents on the HPV
vaccination. No compensation was provided for participation.
Survey Instrument
The research team developed a self-administered survey. The Student Nurse
Survey items were drawn from measures used in prior published studies of HPV
vaccination uptake (Widdice et al., 2011; Kessel et al., 2012), skills satisfaction
(Guilamo-Ramos et al., 2011a), and HPV endorsement outcome expectancies (McRee,
Gilkey, & Dempsey, 2014). The survey included sections on demographics, students’
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vaccination status, intent to receive vaccination, intent to counsel parents on the HPV
vaccine, skills satisfaction as both a parent sexual health communication counselor and
adolescent sexual health educator, HPV endorsement outcome expectancies, and factors
associated with vaccine initiation and completion.
Demographics
To assess race/ethnicity, students were asked if they identified as Hispanic,
Caucasian, African-American, Asian, American Indian or Native American, Multiracial,
and something else. We created a category called “Other” that included those who
identified as American Indian, multiracial, or something else. Marital status was
measured by asking students if they were single/no partner, single/living with partner,
married, divorced, separated/living in different households, widowed with no partner, or
other. This variable was collapsed into two categories: single with no partner vs. living
with partner/married due to low frequencies of the other response options. Religion was
assessed by asking students if they identified as Atheist or Agnostic, Buddhist, Christian,
Hindu, Jewish, Muslim, and other. However, due to low frequencies of many of these
options, the variables were collapsed into two categories: Christian and Other.
Vaccination Status
Students’ vaccination status including vaccine non-initiation, initiation, and
completion were assessed through students’ self -report. Non-initiation was defined as an
individual who had not received any dose of the HPV vaccine series. Initiation of HPV
vaccination was defined as whether an individual had ever received at least one dose of
the three-dose series. Completion of HPV vaccination series was defined as whether an
individual had completed all three doses of HPV vaccination series.

53

The primary outcome variable was HPV vaccination status. To assess this,
students were asked: (1) Did you receive dose one of the three dose HPV series?, (2) Did
you receive dose two of the three dose HPV series?, and (3) Did you receive dose three of
the three dose HPV series?. Responses were coded 1 (yes) and 2 (no). Students who had
not received any dose of the HPV vaccine series were included in the “Non-Initiators”
category. All students who obtained at least one HPV vaccination were included in the
“Initiators” category. Among initiators, students who did not complete the series were
categorized as “Non-Completing Initiators” and those that obtained all three doses of the
vaccine were categorized as “Completers”.
Factors Influencing Personal Vaccination
Factors associated with vaccination status were assessed using three questions
with nine response options developed from Kessel et al. (2012). Students were asked: (1)
What was the most important factor that determined when you received the HPV shots?;
(2) What is the most important factor that will determine when you will complete the
HPV vaccination series?; and (3) What is the main reason you have not completed the
HPV series in the next 12 months?
Skills Satisfaction as both a Sexual Health Parent Communication Counselor
and Adolescent Health Educator
Participants were asked about their current level of confidence in providing
counseling and education using 14 items validated (=0.65) in previous research from a
comparative study of interventions for delaying the initiation of sexual intercourse among
Latino and black youth developed by Guilamo-Ramos et al. (2011a). Students were asked
to rate their level of satisfaction as both a parent communication counselor and
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adolescent health educator prior to any training. Students responded to items that asked
such things as: “At this moment in time how satisfied do you feel with your confidence in
counseling parents on how to talk with youth about sex?” and “At this moment in time,
how satisfied do you feel with your ability to discuss prevention of sexually transmitted
infections (STIs)?” Responses were coded on a 5-point Likert scale (1= Not at all
satisfied to 5= very satisfied).
HPV Endorsement Outcome Expectancies
The HPV endorsement outcome expectancies scale was used to assess students’
beliefs toward HPV vaccine endorsement using eight items from the Minnesota Health
Care Provider Survey developed by McRee, Gilkey, & Dempsey (2014). The scale was
validated in a previous study using cognitive interviews with five healthcare providers to
identify potential sources of response error and to ensure the clarity of new survey items.
Students reported their beliefs toward HPV vaccine endorsement with the following
statements: “When parents wish to delay or refuse HPV vaccination, there is not much I
can say to change their minds” and “I am confident that I can address parental HPV
vaccine concerns about adolescent sexual activity” The response options used a 5-point
Likert scale of “strongly agree”, “somewhat agree”, “somewhat disagree”, “strongly
disagree”, and “I have no experience with this”.
Intentions to Counsel Parents on HPV Vaccination among Student Nurses
Students’ intention to counsel parents on HPV vaccination were assessed with
two items developed by Guilamo-Ramos et al. (2011b) in their study a parent-based
intervention to reduce sexual risk behavior in early adolescence: Building alliances
between physicians, social workers, and parents. Students were asked to respond to the
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following statements, “I plan to counsel parents about the importance of vaccinating
youth against HPV.” and “I plan to counsel youth about the importance of getting the
HPV vaccine at the recommended age.” Responses were coded on a 5-point Likert scale
(1= Strongly disagree to 5 = strongly agree).
Students’ Perception of Parental Barriers to HPV Vaccine Uptake
Perceived parental barriers were assessed with items from the Minnesota Health
Care Provider Survey developed by McRee, Gilkey, & Dempsey (2014). The scale was
validated in a previous study using cognitive interviews with five healthcare providers to
identify potential sources of response error and to ensure the clarity of new survey items.
In this study students were asked one question with 13 items related to their perception of
parental barriers to HPV vaccine uptake. Specifically, students were asked, “Based on
your experience in the past year, how much do each of the following contribute to
parents' decisions to delay or refuse HPV vaccination?” with responses such as “Belief
that HPV is not severe enough to warrant vaccination.” Responses ranged from 1 (not at
all) to 4 (a lot).
Tools and Strategies for Counseling HPV Vaccine-Hesitant Parents
Helpfulness of tools when counseling was assessed using one question with eight
items from the Minnesota Health Care Provider Survey developed by McRee, Gilkey, &
Dempsey (2014). The scale was validated in a previous study using cognitive interviews
with five healthcare providers to identify potential sources of response error and to ensure
the clarity of new survey items. Students were asked, “How much would the following
strategies and tools help you when counseling parents who are hesitant to get HPV
vaccine for their adolescent children?” An example of an item for evaluation is
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“Providing information about HPV vaccine to parents before the clinical visit.”
Responses were on a 4 –point Likert scale ranging from 1 (not at all) to 4 (a lot).
Statistical Analysis
Survey data was analyzed using IBM SPSS Statistical Package for Social
Sciences (version 25) for Mac. First, descriptive statistics were used to analyze the
distribution of demographic variables (mean, standard deviation, frequencies and/or
percentages) and stratify participants based on vaccination status (non-initiators,
initiators, and completers) (Table 1). P values less than 0.05 were considered statistically
significant for all analyses.
Bivariate frequencies and chi-squared test were then calculated to compare each
independent variable (age, race, ethnicity, marital status, and religion) to the outcome
variables, HPV vaccine initiation and completion. The variables considered for the final
multivariable were statistically significant at the bivariate level (p<0.05) with HPV
vaccine initiation and completion were included in a multivariable logistic regression
model to predict vaccine initiation and completion.
Bivariate associations of age and marital status with HPV vaccination completion
were examined using logistic regression model, expressed as unadjusted odds rations
(OR) and 95% confidence intervals (CI) (Table 2). For logistic regression analyses, HPV
vaccination completion was categorized as a dichotomous (yes/no) dependent variable.
Age and marital status with HPV vaccine completion were then examined using
multivariable logistic regression model, as these two factors were significantly associated
with HPV vaccine completion in bivariate analyses (p0.05). The quality of the model
was assessed using Hosmer-Lemeshow fit statistics.
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Univariate descriptive statistics (mean, standard deviation, frequencies and/or
percentages) were computed to analyze the distribution of each variable (HPV
endorsement, skills satisfaction as a sexual health parent communication counselor and
adolescent sexual health educator, intentions to counsel, perception of parental vaccine
hesitancy, and helpful tools to assist with counseling). Next, independent sample t-tests
were used to assess for mean differences between non-initiators vs. initiators and
initiators vs. completers in HPV endorsement outcome expectations, skills satisfaction as
a parent sexual health communication counselor, and skills satisfaction as an adolescent
sexual health educator (Table 3). We examined intentions to counsel parents on HPV
differences between non-initiators vs. initiators and initiators vs. completers using MannWhitney U test, due to a non-normal distribution of the data (Table 4).
Results
Sample Characteristics
Data were collected from a total of 153 student nurses. The mean age of all
students was 24.5 (SD=5.95), with 73% (n=112) aged between 18 and 26 years. The
majority of participants were non-Hispanic (n=111, 73%) and self-identified their race as
either Caucasian (n=97, 63.4%), Asian (n=23, 15%), African-American (n=15, 9.8%) or
other race (n=18, 11.8%). Nearly, three-fourths of participants (n=107, 70%) were
single, with 30% (n=46) stating they were married or living with a partner. The vast
majority of participants declared they were religious (n=133, 87%); among them, 73%
(n=111) self-identified as Christian (Table 1).
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HPV Vaccination Status
Forty-two percent (n=64) of students reported that they had not received any
doses of the HPV vaccine (Table 1). More than half (n=89, 58%) of students reported that
they had received at least one dose of the HPV vaccine series. Of students who had
initiated the vaccine series, 42% (n=65) reported that they had received all three doses of
the HPV vaccine. Caucasians (n=56, 62.9%) and Hispanics (n=29, 32.5%) were more
likely to initiate the HPV vaccine when compared with Asian (n=13, 14.6%), AfricanAmerican (n=10, 11.2%), and those who identified as other (n=10, 11.2%). Caucasian
and Hispanic students had higher rates of HPV vaccine completion (n=40, 61.5%; and n=
19, 29% respectively) when compared with Asian (n=9, 13.8%), and African-American
students (n=9, 13.8%), and students who identified as other race (n=7, 10.8%).
Factors Associated with Three Dose HPV Vaccine Completion
Chi-squared tests indicated a significant relationship between HPV vaccine
completion and marital status, X2 (3, N = 153) = 20.11, p < .000 among those who had
received at least one dose of HPV vaccine (initiators). In addition, the relationship
between vaccine completion and age was significant, (t (151) = 4.36, p = .00) among
completers and non-completers. The percentage of students who were vaccine noncompleters and completers did not differ by race (X2 (4, N = 147) = 3.55, p > .47),
ethnicity (X2 (1, N = 153) = .18, p > .67), or religion (X2 (8, N = 152) = 7.83, p > .45)
(data not shown). Therefore, only age and marital status were included the logistic
regression.
To further explore vaccination completion, a binary logistic regression model was
conducted among non-completers and completers. In the regression model, marital status
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was significantly associated with vaccination completion as well as age. Students who
identified as single (OR: 2.65; 95% CI: 1.09-6.42, p= .031) were almost three times more
likely to complete the HPV vaccine series than those who were married. Age (OR: 0.86;
CI: 0.78-0.95; p=.003) was significantly associated with a decreased likelihood of
vaccine completion; an increase of one year in age was associated with a 14% reduction
in the odds of vaccine completion. The Hosmer-Lemeshow fit statistics indicated
acceptable model fit (χ2=8.50, p=.39) (Table 2).
Factors Influencing Personal Vaccination Status
Among those who had received at least one dose of the vaccine series (n=89),
students reported that the most important factors that influenced vaccine initiation were
having a doctor’s recommendation (n=25, 39%), confidence in the HPV vaccine (n=24,
27%), having a parent who recommended the vaccine (n=9, 14%), and having enough
knowledge about HPV disease and the vaccine (n=9, 14%). The most commonly cited
factors that influenced vaccine completion were: age (<26) (n=21, 24%), receiving a
doctor’s recommendation (n=17, 19%), and convenience of receiving the vaccine (n=15,
17%). The most common reasons for not completing the HPV series among non-initiators
and non-completing initiators were age eligibility (>26 years of age) (n=17, 26%), lack of
provider recommendation (n=14, 16%), intention to complete the HPV series but have
not yet (n=12, 14%), and not being sexually active (n=7, 8%).
Next, we assessed for differences in factors that may influence student nurses’
role as a parent child communication counselor, sexual health educator, and provider of
HPV vaccination endorsement. We compared non-initiators vs. initiators and initiators
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vs. completers on their HPV endorsement, counseling outcomes, skills, and intentions to
counsel parents on HPV vaccination.
Skills Satisfaction as a Parent Sexual Health Communication Counselor
There were no significant differences in skills satisfaction as a parent sexual
health communication counselor score between non-initiators vs. initiators, as well as
initiators and completers (Table 3). An independent sample t test indicated that initiators
(M=9.62, SD=3.95) scored higher on the skills satisfaction as a parent sexual health
communication counselor than non-initiators (M=8.94, SD= 3.98), (t (151) = 1.047, p =
.297). Initiators had higher skills satisfaction as a parent sexual health communication
counselor scores (M=9.50, SD=4.28) when compared with completers (M=9.11,
SD=3.51), (t (151) = .603, p= .547).
Skills Satisfaction as an Adolescent Sexual Health Educator
There were no significant differences in skills satisfaction as an adolescent sexual
health educator score between non-initiators vs. initiators, as well as initiators and
completers (Table 3). An independent sample t test indicated that initiators (M=27.30,
SD=8.74) scored higher on the skills satisfaction as an adolescent sexual health educator
than non-initiators (M=25.70, SD=8.29), (t (151) =1.140, p=.256). Initiators had higher
skills satisfactions scores as an adolescent sexual health educator (M=26.99, SD=8.88)
than completers (M=26.15, SD=8.17), (t (151) =.594, p= .553).
HPV Endorsement Outcome Expectancies
Independent sample t tests found no statistically significant differences in mean
HPV endorsement outcome expectancies scores between non-initiators vs. initiators, as
well as initiators vs. completers (Table 3). Initiators had higher HPV endorsement
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outcome expectancies scores (M =17.44, SD =3.96) than non-initiators (M=17.23,
SD=4.13), (t (151) =.288, p=.774). Additionally, when we compared initiators to
completers, completers reported higher levels of HPV endorsement outcome expectancies
scores (M=17.39, SD=4.10) than initiators (M=17.32, SD=3.99), (t (151) =-.087,
p=.931).
Intentions to Counsel Parents on HPV Vaccination among Student Nurses
For intention to counsel parents on HPV, scores were higher for initiators (mean
rank = 79.10) than non-initiators (mean rank =74.08) (Table 4). A Mann-Whitney U test
indicated that there was no difference in intentions to counsel parents on the HPV
vaccination (U = 2661, Z= -.952, p=.341) between non-initiators and initiators. In
addition, vaccine completers scored higher (mean rank =78.27) on intention to counsel
parents on HPV vaccine than initiators (mean rank =76.06). However, a Mann-Whitney
U test showed that this difference was not significant, (U = 2777.50, Z= -.419, p= .675).
Students’ Perception of Parental Barriers to HPV Vaccine Uptake
In terms of reasons for HPV vaccine delay or refusal, most students perceived
factors that contributed to parents’ decisions were: the belief that their child is not
sexually active (n=73, 57%) and discomfort talking with their child about sex (n=64,
53.1%). Among students who provided data (n=128), perceived factors that contributed
“a little” or “not at all” to parental decision to delay or refuse HPV vaccination for their
child included the belief that HPV vaccine is not very effective (n=99, 77.3%), parent’s
let their children decide and the child refused the vaccine (n=99, 77.3%), and child was
sick at the time of visit (n=101, 78.9%). In addition, students perceived that concern that
their child will suffer immediate short-term effects (n=94, 73.4%) and/or long-term
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complications from HPV vaccine (n=94, 73.4) also contributed “a little” or “not at all” to
parental delay or refusal of the HPV vaccine.
Tools and Strategies for Counseling HPV Vaccine- Hesitant Parents
Student nurses (n=140) reported a range of attitudes about strategies and tools for
counseling vaccine-hesitant parents. The strategies and tools that student nurses
perceived would be most helpful (i.e., “a lot” or “somewhat”) for counseling parents who
are hesitant to get their adolescent children vaccinated against HPV were: information
tailored to patients’ cultural background (n=122, 87%), or specific to parent concerns
(n=125, 89%), and providing information for parents and adolescents separately (n=106,
76%). Students nurses perceived that providing information about the HPV vaccine to
parents prior to the clinical visit (n=102, 73%) and giving interactive decisional aids to
prioritize their health values (n=113, 81%) would also beneficial to counsel parents.
Discussion
There are many concerns about reaching high rates of vaccine uptake and
completion among young adults. Student nurses represent the next generation of
healthcare providers and are in a position to influence vaccine uptake through their own
personal and professional health choices, decision regarding future children and patients,
and willingness to provide vaccine counseling and endorsements. As HPV- associated
cancers rates steadily rise and vaccine uptake remains low, it is necessary to identify
factors that could influence HPV vaccine uptake among this population.
The findings from this analysis indicate that student nurses had low rates of HPV
vaccine initiation (n=89, 57%). Additionally, completion rates were far below Healthy
People 2020 goal of 80 percent coverage (n=65, 42%). We found that the vaccination
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prevalence in this study was comparable to previous studies in college students which
have ranged from 25% to 62.8% for initiation (Licht et al., 2010; Marchand et al., 2012;
Marchand et al., 2013; Rahman, Laz, McGrath, & Berenson, 2014; Wilson et al., 2016)
and 27% to 60.7% for completion (Canfell et al., 2015; LaJoie et al., 2018; Rahman, Laz,
McGrath, & Berenson, 2014; Wilson et al., 2016). These proportions are also parallel to
recent national estimates that 48.5% of eligible women and 13.5% of men 19 to 26-yearold adults have initiated the HPV vaccine (Lewis & Markowitz, 2018). These findings
indicate that continued efforts to improve catch-up vaccination and eliminate missed
vaccination opportunities among young adults are urgently needed.
The majority of participants in the study were under the age of 26 (n=113,
72.4%). At the time of the study, the HPV vaccine was recommended for young women
through age 26; young men through age 21; and through age 26 for young men who have
sex with men, young men who identify as gay or bisexual or who intend to have sex with
men, young adults who are transgender, and young adults with certain
immunocompromising conditions (including HIV) (CDC, 2018b). Of those over the age
eligibility requirements at the time of the study (n=41, 25.8%), many expressed interests
in receiving the vaccine. For this group of adults, it is not too late to vaccinate against
HPV as the FDA recently approved expanding the use of the Gardasil 9 HPV vaccine to
include all women and men through 45 years of age (U.S. Food and Drug Administration,
2018).
The proportions of students who initiated the vaccine in the current sample
differed by race/ethnicity. We found that Caucasians were more likely to report initiation
and completion of the three-dose series when compared with other racial/ethnic groups.
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These findings are similar to national estimates, which recently showed that Caucasian
(adults aged >19) (48.5%) are more likely to initiate the HPV vaccine when compared
with African-American (37.7%) and young Hispanic adults (33%) (Williams et al.,
2017). Studies report ethnic minority populations are willing to accept vaccination;
however cultural differences may create barriers to vaccine uptake (Holman et al., 2014).
Therefore, it is important to develop culturally relevant educational programs that could
potentially increase HPV vaccine uptake and completion among minority racial and
ethnic groups.
In our study, we found that higher vaccination completion was associated with
being unmarried. This might be related to a greater perceived risk for HPV infection
among unmarried student nurses. Students who reported being married or single but
living with a partner were less likely to have completed the HPV vaccination series,
possibly because these students may not believe they are at risk of contracting STIs and
therefore, may be less likely to get vaccinated. These findings are consistent with
previous research indicating that women who were single were significantly more likely
than married women to be interested in the HPV vaccine (Thompson, Sappenfield,
Straub, & Daley, 2016b). These findings suggest that relationship status may influence
HPV vaccination uptake, by impacting risk perceptions and perceived need for the HPV
vaccine. Additionally, efforts aimed at improving HPV vaccination rates should focus on
highlighting lifetime risk for acquiring HPV among young adults in relationships.
Our findings revealed that having a doctor’s recommendation was the most
influential factor associated with vaccine initiation and completion among student nurses.
One study found that those who received a doctor’s recommendation were over 35 times
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more likely to receive at least one dose of HPV vaccine when compared to those who did
not receive a recommendation (Gerend, Shepherd, Lustria, & Shepherd, 2015). Our study
highlights that young adults consider the role that healthcare providers play in health
promotion and disease prevention to be important. This is of particular concern because a
lack of doctor recommendation was cited as a reason for non-initiation and completion of
the HPV vaccine series among undervaccinated students. One probable reason for low
HPV vaccination rates is that young adults are not receiving routine vaccine
recommendations. Failure to discuss vaccination may result in missed clinical
opportunities for receipt of the HPV vaccination, which may ultimately lead to the
development of more HPV-related cancers each year.
In this study, we attempted to identify whether differences existed in students’
intentions to counsel, outcome expectations, skills satisfaction as both a sexual health
parent communication counselor and adolescent sexual health educator by vaccination
status. There was no significant difference between the two groups (non-initiators vs.
initiators and initiators vs. completers). These findings suggest that vaccination status did
not substantially impact students’ beliefs about counseling, skills satisfaction, outcome
expectations, or intentions to counsel parents about the HPV vaccination.
Overall, all scores were high indicating that students had high levels of
confidence in their ability to provide communication counseling, sexual health education,
and overcome HPV vaccine hesitancies. Studies indicates that a nurses’ personal beliefs
and self-confidence to address vaccine concerns often drive their vaccine endorsement
practices (Paterson et al., 2016; Wamai et al., 2013). Unvaccinated students had high
mean intentions to counsel scores, despite being unvaccinated. These findings suggest
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that students’ intention to counsel may also be influenced by their personal attitudes
toward the HPV vaccination. Among the student nurses who participated in our study,
those who initiated and completed the vaccine series had higher mean intentions to
counsel scores. Our findings suggest that personal HPV vaccine uptake among student
nurses may influence their vaccine endorsement practices. These findings are consistent
with previous research that suggest vaccinated nurses and those who express a
willingness to be vaccinated are more likely to recommend the HPV vaccination
(Paterson et al., 2016). Moreover, findings suggest that the influences of their own
vaccine confidence, outcome expectancies, and vaccination uptake play a key role in their
HPV vaccine endorsement practices. Improving providers’ vaccination uptake and
confidence to address parental concerns may be important for promoting HPV vaccine
recommendations and ultimately improving HPV vaccine completion rates, in a broader
age range.
Our findings indicate that student nurses perceived parental barriers such as the
belief that their child is not sexually active, discomfort talking with their child about sex,
and belief that their child was unlikely to get an HPV-related disease, as contributing
factors impacting HPV vaccination rates. This is consistent with previous literature which
suggest that factors such as reluctance to discuss sexual health, child’s age, and low
perception of risk as common barriers to HPV vaccine endorsement, uptake, and
completion among patients and providers (McRee, Gilkey, & Dempsey, 2014; Mills et
al., 2016). Differences in risk perception between healthcare providers and patients, may
also pose increase risk to health. Further studies are needed to raise awareness about
HPV risk among parents, patients, and healthcare providers, followed by development of
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tailored educational tools and strategies to facilitate better communication between
parents, patients, and healthcare providers.
Limitations and Strengths
Limitations of the study included the use of previously collected data and selfreported measures. Additionally, participants were recruited using a purposive sample of
student nurses from one Bachelor of Science Nursing school in an urban area which may
limit the generalizability of findings. Additionally, while we did not assess gender,
student nurses are majority female; this may be seen as a limitation since vaccination
rates differ by gender have been well-documented (Daniel-Ulloa, Gilbert, & Parker,
2016).
Despite these limitations, the focus on student nurses is an innovative approach
for HPV vaccine research. This research will provide insight on young adults as student
nurses, who are transitioning into the nurse role, where they will have the opportunity to
promote the HPV vaccination and reduce missed opportunities for HPV prevention. The
study findings will provide direction for interventions and programs targeted toward
young adults and healthcare providers vaccination concerns which may increase
awareness, HPV vaccine recommendations, uptake, and completion.
Conclusion
Given the growing epidemic of HPV infection, more research is needed,
particularly for high risk populations and future healthcare providers which may increase
vaccine promoting behaviors and impact clinical practice. Although, acceptance of HPV
vaccination is promising, uptake and completion rates remain low among young adults
that are at highest risk for HPV- related disease burdens. Our findings suggest that low
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HPV vaccination rates persist among college students, specifically student nurses.
Additionally, our findings indicate that student nurses who had initiated and/or completed
the HPV vaccine series had higher intentions to recommend vaccination to parents.
Therefore, it is important to develop targeted interventions to increase vaccination rates
among student nurses, not only to protect them from HPV but also because of the impact
that their vaccination status has on their intention to counsel parents.
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Table 1
Sample Characteristics by HPV vaccination status among student nurses (n=153)
Variables
Non-initiators
Initiators
(n=64)
(n=89)
Demographics
Non-Completing
Completers
Initiators
(n=65)
(n=24)
Age in years, M (SD)
 26, n (%)
26, n (%)
Ethnicity, n (%)
Hispanic
non-Hispanic
Race, n (%)
Caucasian
Asian

Total
(n=153)

36 (56)
28 (44)

20 (83)
4 (17)

56 (86)
9 (14)

24.5 (5.95)
112 (73.2)
41 (26.8)

13 (20)
51 (80)

10 (42)
14 (58)

19 (29)
46 (71)

42 (27.4)
111 (72.6)

41 (64)
10 (15.6)

16 (66.6)
4 (16.6)

40 (61.5)
9 (13.8)

97 (63.4)
23 (15)

African-American
5 (7.8)
1 (4.1)
9 (13.8)
Othera
8 (12.5)
3 (12.5)
7 (10.8)
Marital Status, n (%)
Single/Not in a
33 (52)
18 (75)
56 (86)
relationship
Married /Living
31 (48)
6 (25)
9 (14)
with partner
Religion, n (%)
Christian
45 (70)
17 (70.8)
49 (75.3)
b
Other
19 (30)
7 (29)
16 (25)
Note. a
Other: American Indian or Native American; Multiracial; Something else
b
Other: Atheist, Buddhist, Hindu, Jewish, Muslim, None of the above, Refuse to answer

15 (9.8)
18 (11.8)
107 (70)
46 (30)

111 (72.6)
42 (27.4)
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Table 2
Factors associated with vaccination completion (completers vs. all other groups) among student nurses.

Coefficient B

SE

OR

p

95% CI of OR

Age

-.149

.050

0.86

.003

0.78-0.95

Marital Status

.975

.452

2.65

.031

1.09-6.42

*CI=confidence interval
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Table 3
Independent Sample t test comparing non-initiators and initiators
Variable

Group

N

Mean

Std. Deviation

Std. Error
Mean

t

Sig. (2-tailed)

Skills Satisfaction as a Sexual Health
Parent Communication Counselor

non-initiators

64

8.94

3.984

.498

1.047

.297

initiators

89

9.62

3.956

.419

non-initiators

64

25.70

8.295

1.037

1.140

.256

initiators

89

27.30

8.748

.927

non-initiators

56

17.23

4.138

.553

.288

.774

initiators

78

17.44

3.966

.449

initiators

88

9.50

4.283

.457

.603

.547

completers

65

9.11

3.518

.436

initiators

88

26.99

8.880

.947

.594

.553

completers

65

26.15

8.176

1.014

initiators

77

17.32

3.995

.455

-0.87

.931

completers

57

17.39

4.100

.543

Skills Satisfaction as Adolescent
Sexual Health Educator

HPV Endorsement Outcome
Expectancies

Independent Sample t test comparing initiators and completers
Skills Satisfaction as a Sexual Health
Parent Communication Counselor

Skills Satisfaction as Adolescent
Sexual Health Educator

HPV Endorsement Outcome
Expectancies
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Table 4
Mann-Whitney U comparing non-initiators and initiators
Variable

Group

N

Mean
Rank

Sum of
Ranks

U

Z

p

Intentions to Counsel
Parents on HPV
vaccination

non-initiator

64

74.08

4741

2661

-.952

.341

initiator

89

79.10

7040

Total

153
Sum of
Ranks

U

Z

p

2777.500

-.419

.675

Mann-Whitney U comparing initiators and completers
Variable
Group
N
Mean
Rank
Intentions to Counsel
Parents on HPV
vaccination

Initiator

88

76.06

6693.50

Completer

65

78.27

5087.50

Total

153
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Table 5
Determining factors for HPV vaccination status among student nurses.
Initiators

Total
(n)

%

NI

I

What is the most important factor that will determine when you will complete the HPV vaccination series?
Other, please specify

17

4

21

24

The doctor's recommendation
If it is convenient for me to get vaccinated/ If I find the time to do so
Don’t Know
Insurance covering the cost/No cost concerns
If it becomes common practice/ Been standard for years/Comfortable with recommendation
When I know enough about HPV disease and the vaccine
Becoming sexually active
Having enough information about vaccine safety

11
8
13
4
5
3
2
1

6
7
0
4
2
0
0
1

17
15
13
8
7
3
2
2

19
17
15
9
8
3
2
2

25
13
9
8
6
2
1
1

39
20
14
12
9
3
2
2

What was the most important factor that determined when you received the HPV shot?
The doctor's recommendation
It became common practice/It has been standard for years/I was comfortable with recommendation
Other, please specify
I knew enough about HPV disease and the vaccine
Don’t Know
I became sexually active
My insurance covered the cost/No cost concerns
I had enough information about vaccine safety
What is the main reason you will not/have not completed the HPV series in the next 12 months?
Other, please specify: age eligibility
My provider did not recommend it
I intend to complete the HPV series but have not yet/Already planned
Don't know
I am not sexually active
The school does not require
I am uninsured/My insurance does not fully cover shots/The insurance co-pay or other costs are too high (i.e., administration
fees and/or office visit charges)
I did not know about the vaccine/I did not know the vaccine was recommended for me
I do not believe the vaccine is needed or necessary

C

25
13
9
8
6
2
1
1

14
13
4
8
7
5
5

8
1
8
3
0
1
1

22
14
12
11
7
6
6

25
16
14
13
8
7
7

3
3

0
0

3
3

3
3
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Table 6
Students’ perceptions of reasons for parental HPV vaccine hesitancy and helpfulness of
potential tools
A
lot
%

Some
%

A
little
%

Not at
all %

Belief that their child is not sexually active

44

29

17

38

Discomfort talking with their child about sex.

37

31

17

43

Belief that their child is unlikely to get an HPV-related disease.

25

31

29

43

Concerns about vaccines in general.

14

36

27

50

Belief that HPV is not severe enough to warrant vaccination.

13

28

30

58

Concern about the cost of HPV vaccine.

10

35

23

59

Concern about getting multiple vaccines at the same visit.

10

25

37

53

Belief that HPV vaccine recommendations are driven by profit
considerations of drug companies.
Concern that their child will suffer immediate, short-term effects
(such as fever, pain)
Concern that their child will suffer long-term complications from
HPV vaccine.
Parents let their children decide and the child refused the vaccine.

9

25

23

71

8

26

34

60

7

38

21

61

5

22

22

77

Belief that HPV vaccine is not very effective.
Child was sick at the time of visit.

4
3

25
22

26
27

73
74

90

32

13

5

84
72
65

41
40
37

9
22
29

6
6
9

64
64

51
49

18
20

7
7

63
61

43
48

26
24

8
7

Perceived reasons for parental delay or refusal of HPV
vaccine for their child

Helpfulness of potential tools of counseling HPV-vaccine
hesitant parents
Written information for parents that is tailored to their cultural
background.
Information sheets or brochures tailored to specific parent concerns.
A screener to identify specific parent concerns.
Providing information about HPV vaccine to parents before the
clinical visit.
A discussion guide or script for health care professionals.
Interactive decision aids that help parents prioritize their health
values in relation to HPV vaccination.
Providing information for parents and adolescents separately.
More attractive/accessible version of standard Vaccine Information
Sheets.

Note. Presented in descending order by variable mea
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APPENDIX A
THEORY OF PLANNED BEHAVIOR (TPB)
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APPENDIX B
STUDENT NURSE SURVEY
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FTT+HPV Student Nurse Survey (Pre-Test)

Start of Block: Study ID
Q167 Current Year:

2015 (1)

2016 (2)

2017 (3)

Q168 Current Semester:

Fall (1)

Spring (2)

Summer (3)

Q169 Please enter Study ID in the box below:
________________________________________________________________
End of Block: Study ID
Start of Block: Demographics
Q69 How old are you?
________________________________________________________________

Q70 Are you Hispanic or Latino?

Yes (1)

No (2)
Skip To: Q72 If Are you Hispanic or Latino? = No
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Q71 Which category best describes your Hispanic or Latino background?

Puerto Rican (1)

Dominican or Dominican American (2)

Mexican or Mexican American (3)

Cuban or Cuban American (4)

Central American (5)

South American (6)

Q72 What is your race or ethnicity?

White (1)

Black or African American (2)

Asian or Pacific Islander (3)

American Indian or Native American (4)

Other, please specify: (5)
________________________________________________

Q238 What language do you predominately speak at home?

English (1)

Spansih (2)

Other (3)

Q77 How much schooling have you completed?

Up to 8th grade (1)

Some High School (2)

Completed High School (3)

Completed my GED (4)

Some College (5)

Bachelors Degree (6)

Some Graduate School (7)

Master's Degree (8)
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Q78 What is your current marital status?

Single/ Living with No Partner (1)

Single/Living with Partner (2)

Married/ Living with Husband (3)

Divorced or Separated/Living in Different Households (4)

Widowed with no partner (5)

Other (6) ________________________________________________

Q79 What is your current religion?

Atheist or Agnostic (1)

Buddhist (2)

Chrisitian (for example Baptist, Catholic, Episcopal, Lutheran, Methodist,
Pentecostal, Presbyterian) (3)

Hindu (4)

Jewish (5)

Muslim or Moslem (6)

Other, please specify: (7)
________________________________________________

None of the above (8)

Refuse to answer (9)

Q80 How important is religion to you?

Not at all important (1)

Somewhat important (2)

Quite important (3)

Very important (4)
End of Block: Demographics
Start of Block: Block 10
Q194 How confident are you in your ability to teach on the following topics:
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Q171 a) The physiology of the sex organs

Prefer not to answer (1)

Do not think it is an appropriate topic (2)

Would not want to teach it (3)

Not sure I could do it (4)

Confident, with a little time for preparation (5)

Confident, may need to use lecture style (6)

Very confident, including leading discussion and answer questions (7)

Q172 b) Pregnancy and birth

Prefer not to answer (1)

Do not think it is an appropriate topic (2)

Would not want to teach it (3)

Not sure I could do it (4)

Confident, with a little time for preparation (5)

Confident, may need to use lecture style (6)

Very confident, including leading discussion and answer questions (7)

Q173 c) Taking care of sexual health

Prefer not to answer (1)

Do not think it is an appropriate topic (2)

Would not want to teach it (3)

Not sure I could do it (4)

Confident, with a little time for preparation (5)

Confident, may need to use lecture style (6)

Very confident, including leading discussion and answer questions (7)

Q174 d) HIV/AIDS

Prefer not to answer (1)

Do not think it is an appropriate topic (2)

Would not want to teach it (3)

Not sure I could do it (4)

Confident, with a little time for preparation (5)

Confident, may need to use lecture style (6)

Very confident, including leading discussion and answer questions (7)

89

Q175 e) Pregnancy prevention methods

Prefer not to answer (1)

Do not think it is an appropriate topic (2)

Would not want to teach it (3)

Not sure I could do it (4)

Confident, with a little time for preparation (5)

Confident, may need to use lecture style (6)

Very confident, including leading discussion and answer questions (7)

Q176 f) Buying and using contraceptives

Prefer not to answer (1)

Do not think it is an appropriate topic (2)

Would not want to teach it (3)

Not sure I could do it (4)

Confident, with a little time for preparation (5)

Confident, may need to use lecture style (6)

Very confident, including leading discussion and answer questions (7)

Q177 g) Abstinence

Prefer not to answer (1)

Do not think it is an appropriate topic (2)

Would not want to teach it (3)

Not sure I could do it (4)

Confident with a little time for preparation (5)

Confident, may need to use lecture style (6)

Very confident, including leading discussion and answer questions (7)

Q178 h) Getting tested for STIs/STDs

Prefer not to answer (1)

Do not think it is an appropriate topic (2)

Would not want to teach it (3)

Not sure I could do it (4)

Confident, with a little time for preparation (5)

Confident, may need to use lecture style (6)

Very confident, including leading discussion and answer questions (7)
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Q179 i) Emotional issues related to sex

Prefer not to answer (1)

Do not think it is an appropriate topic (2)

Would not want to teach it (3)

Not sure I could do it (4)

Confident, with a little time for preparation (5)

Confident, may need to use lecture style (6)

Very confident, including leading discussion and answer questions (7)

Q180 j) Discussing sex with a partner

Prefer not to answer (1)

Do not think it is an appropriate topic (2)

Would not want to teach it (3)

Not sure I could do it (4)

Confident, with a little time for preparation (5)

Confident, may need to use lecture style (6)

Very confident, including leading discussion and answer questions (7)

Q181 k) Talking to parents about sex

Prefer not to answer (1)

Do not think it is an appropriate topic (2)

Would not want to teach it (3)

Not sure I could do it (4)

Confident, with a little time for preparation (5)

Confident, may need to use lecture style (6)

Very confident, including leading discussion and answer questions (7)
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Q182 l) Abortion

Prefer not to answer (1)

Do not think it is an appropriate topic (2)

Would not want to teach it (3)

Not sure I could do it (4)

Confident, with a little time for preparation (5)

Confident, may need to use lecture style (6)

Very confident, including leading discussion and answer questions (7)

Q183 m) Adoption

Prefer not to answer (1)

Do not think it is an appropriate topic (2)

Would not want to teach it (3)

Not sure I could do it (4)

Confident, with a little time for preparation (5)

Confident, may need to use lecture style (6)

Very confident, including leading discussion and answer questions (7)

Q184 n) Homosexuality

Prefer not to answer (1)

Do not think it is an appropriate topic (2)

Would not want to teach it (3)

Not sure I could do it (4)

Confident, with a little time for preparation (5)

Confident, may need to use lecture style (6)

Very confident, including leading discussion and answer questions (7)

Q185 o) Sex in other cultures

Prefer not to answer (1)

Do not think it is an appropriate topic (2)

Would not want to teach it (3)

Not sure I could do it (4)

Confident, with a little time for preparation (5)

Confident, may need to use lecture style (6)

Very confident, including leading discussion and answer questions (7)
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Q186 p) Sexual choices based on values

Prefer not to answer (1)

Do not think it is an appropriate topic (2)

Would not want to teach it (3)

Not sure I could do it (4)

Confident, with a little time for preparation (5)

Confident, may need to use lecture style (6)

Very confident, including leading discussion and answer questions (7)

Q187 q) Oral sex

Prefer not to answer (1)

Do not think it is an appropriate topic (2)

Would not want to teach it (3)

Not sure I could do it (4)

Confident, with a little time for preparation (5)

Confident, may need to use lecture style (6)

Very confident, including leading discussion and answer questions (7)

Q188 r) Masturbation

Prefer not to answer (1)

Do not think it is an appropriate topic (2)

Would not want to teach it (3)

Not sure I could do it (4)

Confident, with a little time for preparation (5)

Confident, may need to use lecture style (6)

Very confident, including leading discussion and answer questions (7)

Q189 s) Anal sex

Prefer not to answer (1)

Do not think it is an appropriate topic (2)

Would not want to teach it (3)

Not sure I could do it (4)

Confident, with a little time for preparation (5)

Confident, may need to use lecture style (6)

Very confident, including leading discussion and answer questions (7)
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Q190 t) Heavy petting

Prefer not to answer (1)

Do not think it is an appropriate topic (2)

Would not want to teach it (3)

Not sure I could do it (4)

Confident, with a little time for preparation (5)

Confident, may need to use lecture style (6)

Very confident, including leading discussion and answer questions (7)

Q191 u) Kissing

Prefer not to answer (1)

Do not think it is an appropriate topic (2)

Would not want to teach it (3)

Not sure I could do it (4)

Confident, with a little time for preparation (5)

Confident, may need to use lecture style (6)

Very confident, including leading discussion and answer questions (7)
End of Block: Block 10
Start of Block: Beliefs
Q58
This section asks you questions about your beliefs. We want you to tell us your
impressions about what happens when parents talk to their teens about sexual intercourse
or monitor their social activities.
Please indicate how strongly you agree or disagree with the following
statements regarding 11-14 year old youth and their parents.

Q1 By talking to youth about NOT having sex, parents would definitely LESSEN the
chances that their child will experience a negative sexual health outcome.

Strongly disagree (1)

Moderately disagree (2)

Neither agree nor disagree (3)

Moderately agree (4)

Strongly agree (5)
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Q2 By setting clear rules and expectations about not engaging in sexual activity, parents
would definitely LESSEN the chances that their child will experience a negative sexual
health outcome.

Strongly disagree (1)

Moderately disagree (2)

Neither agree nor disagree (3)

Moderately agree (4)

Strongly agree (5)

Q3 By keeping track of where youth are, parents would NOT LESSEN the chances that
their child will experience a negative sexual health outcome.

Strongly disagree (1)

Moderately disagree (2)

Neither agree nor disagree (3)

Moderately agree (4)

Strongly agree (5)

Q4 By discouraging youth from dating an older teen, parents would definitely LESSEN
the chances that their child will experience a negative sexual health outcome.

Strongly disagree (1)

Moderately disagree (2)

Neither agree nor disagree (3)

Moderately agree (4)

Strongly agree (5)

Q5 By encouraging youth to have friendships rather than serious dating relationships,
parents would NOT LESSEN the likelihood that their child will experience a negative
sexual health outcome.

Strongly disagree (1)

Moderately disagree (2)

Neither agree nor disagree (3)

Moderately agree (4)

Strongly agree (5)
End of Block: Beliefs
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Start of Block: Block 1
Q59
Now we are going to ask you about your opinions about health-related behaviors and
outcomes among teens in general. Please indicate whether you agree or disagree with the
following statements.

Q7 Given that a child is between the ages of 11 and 14, I realize that there is a chance
s/he could start having sex soon.

Strongly disagree (1)

Moderately disagree (2)

Neither agree nor disagree (3)

Moderately agree (4)

Strongly agree (5)

Q8 Given that more than 50% of minority youth get pregnant before the age of 20, I
should be concerned about teen pregnancy in youth.

Strongly disagree (1)

Moderately disagree (2)

Neither agree nor disagree (3)

Moderately agree (4)

Strongly agree (5)

Q9 Because almost half of all sexually transmitted infections (STIs) occur among youth
ages 15 to 24, I recognize that youth are at high risk for acquiring an STI.

Strongly disagree (1)

Moderately disagree (2)

Neither agree nor disagree (3)

Moderately agree (4)

Strongly agree (5)
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Q10 African Americans or Latino families living in an urban setting face more challenges
than most parents of other ethnic groups in trying to prevent youth from getting HIV.

Strongly disagree (1)

Moderately disagree (2)

Neither agree nor disagree (3)

Moderately agree (4)

Strongly agree (5)

Q11 As teen parenthood is a leading cause of school drop-out, I am deeply concerned
about teen pregnancy in youth.

Strongly disagree (1)

Moderately disagree (2)

Neither agree nor disagree (3)

Moderately agree (4)

Strongly agree (5)
End of Block: Block 1
Start of Block: Block 2
Q60
People have different opinions about why some parents talk to their teens about sexual
intercourse while others do not. This section explores your opinions about things that
might happen if a parent talks with their youth about sex between ages 11-14. Please
indicate whether you agree or disagree with the following statements.

Q12 Talking to youth about sex won't make a difference.

Strongly disagree (1)

Moderately disagree (2)

Neither agree nor disagree (3)

Moderately agree (4)

Strongly agree (5)
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Q13 Talking to youth about sex will lead to them having sex.

Strongly disagree (1)

Moderately disagree (2)

Neither agree nor disagree (3)

Moderately agree (4)

Strongly agree (5)

Q14 I'm too embarrassed to talk to parents about how to talk with youth about sex.

Strongly disagree (1)

Moderately disagree (2)

Neither agree nor disagree (3)

Moderately agree (4)

Strongly agree (5)

Q15 I'm too embarrassed to talk to youth about how to talk with their parents about sex.

Strongly disagree (1)

Moderately disagree (2)

Neither agree nor disagree (3)

Moderately agree (4)

Strongly agree (5)

Q16 I don't know what to say to parents about how to talk with youth about sex.

Strongly disagree (1)

Moderately disagree (2)

Neither agree nor disagree (3)

Moderately agree (4)

Strongly agree (5)

Q17 I don’t know what to say to youth about how to talk with their parents about sex.

Strongly disagree (1)

Moderately disagree (2)

Neither agree nor disagree (3)

Moderately agree (4)

Strongly agree (5)
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Q18 I don't know what to tell a parent who had sex as a teen and doesn’t know how to
address that with their youth.

Strongly disagree (1)

Moderately disagree (2)

Neither agree nor disagree (3)

Moderately agree (4)

Strongly agree (5)

Q19 Teens get enough information about sex at school and they don’t need to hear it
from a parent.

Strongly disagree (1)

Moderately disagree (2)

Neither agree nor disagree (3)

Moderately agree (4)

Strongly agree (5)

Q20 Teens get enough information about sex at school and they don't need to hear it from
a nurse.

Strongly disagree (1)

Moderately disagree (2)

Neither agree nor disagree (3)

Moderately agree (4)

Strongly agree (5)
End of Block: Block 2
Start of Block: Block 3
Q161 For the next set of questions, we want to know your level of satisfaction with your
skills to educate parents about adolescent sexual health.
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Q21 At this moment in time, how satisfied do you feel with your confidence in
counseling parents on how to talk with youth about sex?

Not at all satisfied (1)

A little satisfied (2)

Somewhat satisfied (3)

Mostly satisfied (4)

Very satisfied (5)

Q22 At this moment in time, how satisfied do you feel with your confidence in
counseling youth on how to talk with their parent about sex?

Not at all satisfied (1)

A little satisfied (2)

Somewhat satisfied (3)

Mostly satisfied (4)

Very satisfied (5)

Q23 At this moment in time, how satisfied do you feel with the amount of control you
have over being able to counsel a parent on how to talk with youth about sex?

Not at all satisfied (1)

A little satisfied (2)

Somewhat satisfied (3)

Mostly satisfied (4)

Very satisfied (5)

Q24 At this moment in time, how satisfied do you feel with the amount of control you
have over being able to counsel youth on how to talk with their parents about sex?

Not at all satisfied (1)

A little satisfied (2)

Somewhat satisfied (3)

Mostly satisfied (4)

Very satisfied (5)
End of Block: Block 3
Start of Block: Block 4
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Q61
For the next set of questions, we want to know your level of satisfaction with your skills
as an adolescent sexual health educator.

Q25 At this moment in time, how satisfied do you feel with your ability to discuss
prevention of HIV/AIDS.

Not at all satisfied (1)

A little satisfied (2)

Somewhat satisfied (3)

Mostly satisfied (4)

Very satisfied (5)

Q26 At this moment in time, how satisfied do you feel with your ability to discuss
prevention of sexually transmitted infections (STIs)

Not at all satisfied (1)

A little satisfied (2)

Somewhat satisfied (3)

Mostly satisfied (4)

Very satisfied (5)

Q27 At this moment in time, how satisfied do you feel with your ability to discuss
prevention of teen pregnancy.

Not at all satisfied (1)

A little satisfied (2)

Somewhat satisfied (3)

Mostly satisfied (4)

Very satisfied (5)
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Q28 At this moment in time, how satisfied do you feel with your ability to increase
parent-child sexual health communication.

Not at all satisfied (1)

A little satisfied (2)

Somewhat satisfied (3)

Mostly satisfied (4)

Very satisfied (5)

Q29 At this moment in time, how satisfied do you feel with your ability to increase
parental monitoring.

Not at all satisfied (1)

A little satisfied (2)

Somewhat satisfied (3)

Mostly satisfied (4)

Very satisfied (5)

Q30 At this moment in time, how satisfied do you feel with your ability to increase
parents' beliefs that they can make a difference.

Not at all satisfied (1)

A little satisfied (2)

Somewhat satisfied (3)

Mostly satisfied (4)

Very satisfied (5)

Q31 At this moment in time, how satisfied do you feel with your ability to increase focus
of parental communication on social reasons for decision making.

Not at all satisfied (1)

A little satisfied (2)

Somewhat satisfied (3)

Mostly satisfied (4)

Very satisfied (5)
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Q32 At this moment in time, how satisfied do you feel with your ability to counsel
parents on overcoming communication barriers.

Not at all satisfied (1)

A little satisfied (2)

Somewhat satisfied (3)

Mostly satisfied (4)

Very satisfied (5)

Q33 At this moment in time, how satisfied do you feel with your ability to motivate
parent-child communication using health outcomes.

Not at all satisfied (1)

A little satisfied (2)

Somewhat satisfied (3)

Mostly satisfied (4)

Very satisfied (5)

Q34 At this moment in time, how satisfied do you feel with your ability to counsel
parents on getting the sexual health conversation started.

Not at all satisfied (1)

A little satisfied (2)

Somewhat satisfied (3)

Mostly satisfied (4)

Very satisfied (5)
End of Block: Block 4
Start of Block: Block 5
Q62 We now want to find out some of your general feelings about parental monitoring of
youth sexual behavior and social activities. Remember that when we say “social
activities”, we mean the things teens do for fun when they have free time, such as
hanging out with friends, going to parties, or going out on dates.
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Q35 When youth go out at night, parents should know where they are.

Almost never (1)

Sometimes (2)

A moderate amount of time (3)

Most of the time (4)

All of the time (5)

Q36 Parents should talk with youth about the plans they have with friends.

Almost never (1)

Sometimes (2)

A moderate amount of time (3)

Most of the time (4)

All of the time (5)

Q37 Youth should let parents know who they are going to be with before they go out.

Almost never (1)

Sometimes (2)

A moderate amount of time (3)

Most of the time (4)

All of the time (5)

Q38 Parents should ask youth where they will be when they go out.

Almost never (1)

Sometimes (2)

A moderate amount of time (3)

Most of the time (4)

All of the time (5)

Q39 Parents should know where youth are after school.

Almost never (1)

Sometimes (2)

A moderate amount of time (3)

Most of the time (4)

All of the time (5)
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Q40 Youth should call parents to let them know if they are going to be home late.

Almost never (1)

Sometimes (2)

A moderate amount of time (3)

Most of the time (4)

All of the time (5)

Q41 Parents should set clear expectations for how they expect youth to behave when it
comes to having sexual intercourse at this time in their lives.

Almost never (1)

Sometimes (2)

A moderate amount of time (3)

Most of the time (4)

All of the time (5)

Q42 Parents should follow through if youth break rules or agreements at this time in their
lives.

Almost never (1)

Sometimes (2)

A moderate amount of time (3)

Most of the time (4)

All of the time (5)

Q43 Parents should check in with youth about what is currently going on in their lives.

Almost never (1)

Sometimes (2)

A moderate amount of time (3)

Most of the time (4)

All of the time (5)
End of Block: Block 5
Start of Block: Block 6
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Q63 We now want to find out some of your general feelings about talking to parents and
youth about sexual activity. Remember that when we say “sexual intercourse”, we mean
“going all the way” or the “act by which babies are made.” Sexual intercourse is when a
male inserts his penis into a female’s vagina.

Q44 I plan to counsel parents about the importance of talking with youth about not
having sexual intercourse at this time in his/her life.

Strongly disagree (1)

Moderately disagree (2)

Neither agree nor disagree (3)

Moderately agree (4)

Strongly agree (5)

Q45 I plan to counsel parents about the importance of talking with youth about protecting
him/herself if s/he chooses to have sexual intercourse at this time in his/her life.

Strongly disagree (1)

Moderately disagree (2)

Neither agree nor disagree (3)

Moderately agree (4)

Strongly agree (5)

Q66 I plan to counsel parents about the importance of vaccinating youth against HPV.

Strongly disagree (1)

Moderately disagree (2)

Neither Agree nor Disagree (3)

Moderately agree (4)

Strongly Agree (5)
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Q67 I plan to counsel youth about the importance of getting the HPV vaccine at the
recommended age.

Strongly disagree (1)

Moderately disagree (2)

Neither Agree nor Disagree (3)

Moderately agree (4)

Strongly Agree (5)
End of Block: Block 6
Start of Block: Behavior
Q64 This next set of questions ask about your communication with parents in the past
three months.

Q46 In the past 3 months, have you ever talked with parents about how to talk with youth
about NOT having sexual intercourse at this time in their lives?

Yes (1)

No (2)

Q47 In the past 3 months, how often did you talk with parents about how to talk with
youth about not having sexual intercourse at this time in their lives?

Once (1)

More than once, but less than once per month (2)

About once per month (3)

A few times per month (4)

About once per week (5)

About two or more times per week (6)

Never (8)
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Q48 In the past 3 months, have you ever talked with parents about how to talk with youth
about why social reasons for having sex are not good reasons?

Not at all (1)

A little bit (2)

Somewhat (3)

A moderate amount (4)

A great deal (5)

Q49 In the past 3 months, have you ever talked with parents about how to talk with youth
about the qualities of a healthy relationship between two people?

Not at all (1)

A little bit (2)

Somewhat (3)

A moderate amount (4)

A great deal (5)

Q50 In the past 3 months, have you ever talked with parents about how to talk with youth
about ways to resist peer pressure for having sex?

Not at all (1)

A little bit (2)

Somewhat (3)

A moderate amount (4)

A great deal (5)

Q51 In the past 3 months, have you ever talked with parents about how to talk with youth
about their beliefs on when sex should or shouldn't take place?

Not at all (1)

A little bit (2)

Somewhat (3)

A moderate amount (4)

A great deal (5)
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Q52 In the past 3 months, have you ever talked with parents about how to talk with youth
about their rules about dating?

Not at all (1)

A little bit (2)

Somewhat (3)

A moderate amount (4)

A great deal (5)

Q53 In the past 3 months, have you ever talked with parents about how to talk with youth
about sexually transmitted diseases, such as HIV?

Not at all (1)

A little bit (2)

Somewhat (3)

A moderate amount (4)

A great deal (5)

Q54 In the past 3 months, have you ever talked with parents about how to talk with youth
about using methods of contraception, such as condoms or the pill?

Not at all (1)

A little bit (2)

Somewhat (3)

A moderate amount (4)

A great deal (5)

Q170 In the past 3 months, have you ever talked with parents about the importance of
getting the HPV vaccination for youth?

Not at all (1)

A little bit (2)

Somewhat (3)

A moderate amount (4)

A great deal (5)
End of Block: Behavior
Start of Block: Block 11
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Q82 In the last month, how often have you felt that you were unable to control the
important things in your life?

Never (1)

Almost never (2)

Sometimes (3)

Fairly Often (4)

Very Often (5)

Q83 In the last month, how often have you felt confident about your ability to handle
your personal problems?

Never (1)

Almost never (2)

Sometimes (3)

Fairly Often (4)

Very Often (5)

Q84 In the last month, how often have you felt that things were going your way?

Never (1)

Almost never (2)

Sometimes (3)

Fairly Often (4)

Very often (5)

Q85 In the last month, how often have you felt difficulties were piling up so high that you
could not overcome them?

Never (1)

Almost never (2)

Sometimes (3)

Fairly Often (4)

Very often (5)
End of Block: Block 11
Start of Block: Block 13
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Q163
We would now like to ask about your experience in the past 3 months of providing HPV
vaccination counseling to parents.

Q92
How often will you recommend HPV vaccine to 11-12 year old girls as part of their
routine care?

Never (1)

Rarely (2)

Sometimes (3)

Often (4)

Most of the time (5)

Q90 I prefer to recommend HPV vaccine as an optional vaccine for girls ages 11-12.

Strongly agree (1)

Somewhat agree (2)

Somewhat disagree (3)

Strongly disagree (4)

Q91 I will recommend HPV vaccine for girls ages 11-12 as strongly as other adolescent
vaccines such as Tdap and meningococcal vaccine.

Strongly agree (1)

Somewhat agree (2)

Somewhat disagree (3)

Strongly disagree (4)

Q93
How often will you recommend HPV vaccine to 11-12 year old boys as part of their
routine care?

Never (1)

Rarely (2)

Sometimes (3)

Often (4)

Most of the time (5)
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Q94
I prefer to recommend HPV vaccine as an optional vaccine for boys ages 11-12.

Strongly agree (1)

Somewhat agree (2)

Somewhat disagree (3)

Strongly disagree (4)

Q95 I will recommend HPV vaccine for boys ages 11-12 as strongly as other adolescent
vaccines such as Tdap and meningococcal vaccine.

Strongly agree (1)

Somewhat agree (2)

Somewhat disagree (3)

Strongly disagree (4)

Q96
Please think about times during the past year that you have recommended HPV vaccine
to parents of boys and girls 11-12 years old. How often did parents react in the following
ways?

Q97 Accepted the recommendation for HPV vaccination without question.

Never (1)

Rarely (2)

Sometimes (3)

Often (4)

Most of the time (5)

Q98 Requested to delay HPV vaccination until a future visit.

Never (1)

Rarely (2)

Sometimes (3)

Often (4)

Most of the time (5)

Not applicable (6)
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Q99 Refused HPV vaccination for their child.

Never (1)

Rarely (2)

Sometimes (3)

Often (4)

Most of the time (5)

Q100 Expressed concerns about HPV vaccination.

Never (1)

Rarely (2)

Sometimes (3)

Often (4)

Most of the time (5)

Q101 Appeared offended or angry that you brought up the topic.

Never (1)

Rarely (2)

Sometimes (3)

Often (4)

Most of the time (5)

Q102 Based on your experience in the past year, how much do each of the following
contribute to parents' decisions to delay or refuse HPV vaccination?

Q103 Concern that their child will suffer long-term complications from HPV vaccine.

Not at all (1)

A little (2)

Some (3)

A lot (4)
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Q104 Belief that their child is unlikely to get an HPV-related disease.

Not at all (1)

A little (2)

Some (3)

A lot (4)

Q105 Belief that HPV is not severe enough to warrant vaccination.

Not at all (1)

A little (2)

Some (3)

A lot (4)

Q106 Concern that their child will suffer immediate, short-term effects (such as fever,
pain).

Not at all (1)

A little (2)

Some (3)

A lot (4)

Q107 Belief that HPV vaccine recommendations are driven by profit considerations of
drug companies.

Not at all (1)

A little (2)

Some (3)

A lot (4)

Q108 Belief that HPV vaccine is not very effective.

Not at all (1)

A little (2)

Some (3)

A lot (4)
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Q109 Child was sick at the time of visit.

Not at all (1)

A little (2)

Some (3)

A lot (4)

Q110 Concerns about vaccines in general.

Not at all (1)

A little (2)

Some (3)

A lot (4)

Q111 Concern about getting multiple vaccines at the same visit.

Not at all (1)

A little (2)

Some (3)

A lot (4)

Q112 Belief that their child is not sexually active.

Not at all (1)

A little (2)

Some (3)

A lot (4)

Q113 Discomfort talking with their child about sex.

Not at all (1)

A little (2)

Some (3)

A lot (4)
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Q114 Parents let their children decide and the child refused the vaccine.

Not at all (1)

A little (2)

Some (3)

A lot (4)

Q115 Concern about the cost of HPV vaccine.

Not at all (1)

A little (2)

Some (3)

A lot (4)

Q117
Please think about times during the past year that parents of 11-12 year olds have
responded to your recommendation of HPV vaccine with concern or hesitancy.
When it comes counseling HPV-vaccine hesitant parents, how often did you do the
following?

Q118 Strongly urge parents to initiate the HPV vaccine series at the present time.

Never (1)

Rarely (2)

Sometimes (3)

Often (4)

Most of the time (5)

Q119 Suggest delaying HPV vaccination until an older age, even when eligible for
vaccination.

Never (1)

Rarely (2)

Sometimes (3)

Often (4)

Most of the time (5)
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Q120 Ask questions to explore parents' concerns.

Never (1)

Rarely (2)

Sometimes (3)

Often (4)

Most of the time (5)

Q121 Provide written materials, such as vaccine Information Sheets, to inform parents.

Never (1)

Rarely (2)

Sometimes (3)

Often (4)

Most of the time (5)

Q122 Offer reassurance that HPV vaccine is safe.

Never (1)

Rarely (2)

Sometimes (3)

Often (4)

Most of the time (5)

Q123 Tell parents that you have vaccinated (or would vaccinate) your own child with
HPV vaccine.

Never (1)

Rarely (2)

Sometimes (3)

Often (4)

Most of the time (5)

Q125 How much you agree or disagree with the following statements?
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Q126 I am usually able to convince hesitant parents to get HPV vaccine.

Strongly agree (1)

Somewhat agree (2)

Somewhat disagree (3)

Strongly disagree (4)

I have no experience with this (5)

Q127 When parents wish to delay or refuse HPV vaccination, there is not much I can say
to change their minds.

Strongly agree (1)

Somewhat agree (2)

Somewhat disagree (3)

Strongly disagree (4)

Q128 I am confident that I can overcome parental concerns about HPV vaccine safety.

Strongly agree (1)

Somewhat agree (2)

Somewhat disagree (3)

Strongly disagree (4)

Q129 I am confident that I can address parental HPV vaccine concerns about adolescent
sexual activity.

Strongly agree (1)

Somewhat agree (2)

Somewhat disagree (3)

Strongly disagree (4)

Q130 I feel I have enough time during appointments to probe parents about their reasons
for wanting to refuse or delay HPV vaccine for their adolescent child.

Strongly agree (1)

Somewhat agree (2)

Somewhat disagree (3)

Strongly disagree (4)

I have no experience with this (5)
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Q131 I am influential in parents’ decision about whether or not to get HPV vaccine for
their adolescent child.

Strongly agree (1)

Somewhat agree (2)

Somewhat disagree (3)

Strongly disagree (4)

I have no experience with this (5)

Q132 I am confident I can address specific parental concerns and questions about HPV
vaccine for boys.

Strongly agree (1)

Somewhat agree (2)

Somewhat disagree (3)

Strongly disagree (4)

Q133 I am more likely to probe about parents’ reasons for hesitancy with other
adolescent vaccines (e.g., Tdap) than with HPV vaccine.

Strongly agree (1)

Somewhat agree (2)

Somewhat disagree (3)

Strongly disagree (4)

Q134 How much would the following strategies and tools help you when counseling
parents who are hesitant to get HPV vaccine for their adolescent children?

Q135 A discussion guide or script for health care professionals.

Not at all (1)

A little (2)

Some (3)

A lot (4)
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Q136 A screener to identify specific parent concerns.

Not at all (1)

A little (2)

Frequently (3)

A lot (4)

Q137 More attractive/accessible version of standard Vaccine Information Sheets.

Not at all (1)

A little (2)

Frequently (3)

A lot (4)

Q138 Information sheets or brochures tailored to specific parent concerns.

Not at all (1)

A little (2)

Frequently (3)

A lot (4)

Q139 Written information for parents that is tailored to their cultural background.

Not at all (1)

A little (2)

Frequently (3)

A lot (4)

Q140 Providing information about HPV vaccine to parents before the clinical visit.

Not at all (1)

A little (2)

Frequently (3)

A lot (4)
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Q141 Interactive decision aids that help parents prioritize their health values in relation to
HPV vaccination.

Not at all (1)

A little (2)

Frequently (3)

A lot (4)

Q142 Providing information for parents and adolescents separately.

Not at all (1)

A little (2)

Frequently (3)

A lot (4)

Q149 Adolescent visits for HPV vaccine are a good opportunity to provide health
education and anticipatory guidance to adolescent patients and their parents.

Strongly agree (1)

Somewhat agree (2)

Somewhat disagree (3)

Strongly disagree (4)

Q150 HPV vaccination is a good opportunity to talk with adolescent patients or parents
about sexual health.

Strongly agree (1)

Somewhat agree (2)

Somewhat disagree (3)

Strongly disagree (4)

Q151 Discussing sex during visits for HPV vaccine may discourage parents from getting
their child vaccinated.

Strongly agree (1)

Somewhat agree (2)

Somewhat disagree (3)

Strongly disagree (4)
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Q152 HPV vaccination is a good opportunity to encourage parents to talk with their
children about sex.

Strongly agree (1)

Somewhat agree (2)

Somewhat disagree (3)

Strongly disagree (4)
End of Block: Block 13
Start of Block: Block 13
Q158 Did you receive dose 1 of the three dose HPV series?

Yes (1)

No (2)
Skip To: Q164 If Did you receive dose 1 of the three dose HPV series? = No

Q159 Did you receive dose 2 of the three dose HPV series?

Yes (1)

No (2)
Skip To: Q164 If Did you receive dose 2 of the three dose HPV series? = No

Q160 Did you receive dose 3 of the three dose HPV series?

Yes (1)

No (2)
Skip To: Q164 If Did you receive dose 3 of the three dose HPV series? = No
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Q157 What was the most important factor that determined when you received the HPV
shots?

The doctor's recommendation (1)
o It became common practice/It has been standard for years/I was
comfortable with recommendation (2)

I knew enough about HPV disease and the vaccine (3)

I became sexually acitve (4)

My insurance covered the cost/No cost concerns (5)

I had enough information about vaccine safety (6)

It was convenient for me to get vaccinated/I found the time to do so (7)

Other, please specify: (8)
________________________________________________

Don't know (9)
Skip To: End of Survey If What was the most important factor that determined when you
received the HPV shots? = The doctor's recommendation
Skip To: End of Survey If What was the most important factor that determined when you
received the HPV shots? = It became common practice/It has been standard for years/I
was comfortable with recommendation
Skip To: End of Survey If What was the most important factor that determined when you
received the HPV shots? = I knew enough about HPV disease and the vaccine
Skip To: End of Survey If What was the most important factor that determined when you
received the HPV shots? = I became sexually acitve
Skip To: End of Survey If What was the most important factor that determined when you
received the HPV shots? = My insurance covered the cost/No cost concerns
Skip To: End of Survey If What was the most important factor that determined when you
received the HPV shots? = I had enough information about vaccine safety
Skip To: End of Survey If What was the most important factor that determined when you
received the HPV shots? = It was convenient for me to get vaccinated/I found the time to
do so
Skip To: End of Survey If What was the most important factor that determined when you
received the HPV shots? = Other, please specify:
Skip To: End of Survey If What was the most important factor that determined when you
received the HPV shots?(Other, please specify:) Is Not Empty
Skip To: End of Survey If What was the most important factor that determined when you
received the HPV shots? = Don't know
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Q164 Are you planning to receive all 3 doses of the HPV series?

Yes (1)

No (2)

I am unsure (3)

Q165 What is the most important factor that will determine when you will complete the
HPV vaccination series?

The doctor's recommendation (1)

If it becomes common practice/Been standard for years/Comfortable with
recommendation (2)

When I know enough about HPV disease and the vaccine (3)

Becoming sexually acitve (4)

Insurance covering the cost/No cost concerns (5)

Having enough information about vaccine safety (6)

If it is convenient for me to get vaccinated/If I find the time to do so (7)

Other, please specify: (8) _____________________________________

Don't know (9)

Q153 What is the main reason you will not/have not completed the HPV series in the
next 12 months?

My provider did not recommend it (1)

The vaccine is not available in provider's office (2)

I did not know about the vaccine/I did not know the vaccine was
recommended for me (3)

I do not believe the vaccine is needed or neccesary (4)

The school does not require (5)

I have safety concerns about it (6)

I am uninsured/My insurance does not fully cover shots/The insurance copay or other costs are too high (i.e., administration fees and/or office visit
charges) (7)

The shot could be painful (8)

I have had difficulty making or getting an appointment/I have had
transportation problems (9)

I intend to complete the HPV series but have not yet/Already planned 10)

I am not sexually active (11)

Other, please specify (12) _____________________________________

Don't know (13)
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Q155 On a scale of 0 to 10, with “0” being “strongly disagree” and 10 being “strongly
agree,” please tell how much you disagree or agree with the following statements. The
HPV vaccine is safe.

0 (1)

1 (2)

2 (3)

3 (4)

4 (5)

5 (6)

6 (7)

7 (8)

8 (9)

9 (10)

10 (11)

Don't Know (12)

Q154 How likely is it that you will receive HPV shots in the next 12 months?

Very Unlikely (1)

Somewhat Unlikely (2)

Neutral (3)

Somewhat Likely (4)

Very Likely (5)

Q156 At what age do you plan to receive the HPV shot?
________________________________________________________________
Q65 We now want to ask you some questions about some other activities you might have
done.

Q55 In the past 3 months, have you participated in any other adolescent sexual health
trainings or educational programs outside of this one?

Yes (1)

No (2)
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Q56 Please list the names of all the health programs that you have participated in during
the past 3 months.
________________________________________________________________

Q57 What was the focus of these programs?
________________________________________________________________
Q195 I am confident in my ability to counsel families about the following topics:

Q196 a) Their child’s weight.

Strongly Disagree (1)

Disagree (2)

Neutral (3)

Agree (4)

Strongly Agree (5)

Q197 b) Making changes in the home environment related to their child’s snacking
behavior.

Strongly Disagree (1)

Disagree (2)

Neutral (3)

Agree (4)

Strongly Agree (5)

Q198 c) Making changes in the home environment related to their child’s intake of sugarsweetened beverages.

Strongly Disagree (1)

Disagree (2)

Neutral (3)

Agree (4)

Strongly Agree (5)
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Q199 d) Making changes in the home environment related to their child’s screen-time.

Strongly Disagree (1)

Disagree (2)

Neutral (3)

Agree (4)

Strongly Agree (5)

Q200 e) Making changes in the home environment related to their child’s involvement in
physical activity.

Strongly Disagree (1)

Disagree (2)

Neutral (3)

Agree (4)

Strongly Agree (5)

Q201 f) Making changes in the home environment to limit snacking in front of the
television.

Strongly Disagree (1)

Disagree (2)

Neutral (3)

Agree (4)

Strongly Agree (5)

Q202 After behavioral counseling, parents will be more likely to do the following:

Q203 a) Increase their own fruit and vegetable intake.

Strongly Disagree (1)

Disagree (2)

Neutral (3)

Agree (4)

Strongly Agree (5)
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Q204 b) Limit their own screen-time to 2 hours per day or less (outside of work).

Strongly Disagree (1)

Disagree (2)

Neutral (3)

Agree (4)

Strongly Agree (5)

Q205 c) Increase their own physical activity.

Strongly Disagree (1)

Disagree (2)

Neutral (3)

Agree (4)

Strongly Agree (5)

Q206 d) Decrease their own intake of sugar-sweetened beverages.

Strongly Disagree (1)

Disagree (2)

Neutral (3)

Agree (4)

Strongly Agree (5)

Q207 e) Refrain from snacking in front of the television.

Strongly Disagree (1)

Disagree (2)

Neutral (3)

Agree (4)

Strongly Agree (5)

Q208 f) Decrease the availability of sugar-sweetened beverages in the home.

Strongly Disagree (1)

Disagree (2)

Neutral (3)

Agree (4)

Strongly Agree (5)
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Q209 g) Limit snacking in front of the television.

Strongly Disagree (1)

Disagree (2)

Neutral (3)

Agree (4)

Strongly Agree (5)

Q210 h) Increase fruits and vegetables available in the home.

Strongly Disagree (1)

Disagree (2)

Neutral (3)

Agree (4)

Strongly Agree (5)

Q211 i) Set household rules limiting screen-time (outside of school work).

Strongly Disagree (1)

Disagree (2)

Neutral (3)

Agree (4)

Strongly Agree (5)

Q212 j) Decrease sugar-sweetened beverages available in the home.

Strongly Disagree (1)

Disagree (2)

Neutral (3)

Agree (4)

Strongly Agree (5)
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Q213 k) Make healthier snack options available in the home.

Strongly Disagree (1)

Disagree (2)

Neutral (3)

Agree (4)

Strongly Agree (5)

Q214 l) Encourage their child to participate in physical activity.

Strongly Disagree (1)

Disagree (2)

Neutral (3)

Agree (4)

Strongly Agree (5)

Q215 m) Believe that fruits and vegetables are important to health.

Strongly Disagree (1)

Disagree (2)

Neutral (3)

Agree (4)

Strongly Agree (5)

Q216 n) Believe that decreasing sugar-sweetened beverages is important to health.

Strongly Disagree (1)

Disagree (2)

Neutral (3)

Agree (4)

Strongly Agree (5)

Q217 o) Believe that the relationship between physical activity and health is important.

Strongly Disagree (1)

Disagree (2)

Neutral (3)

Agree (4)

Strongly Agree (5)
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Q218 p) Believe that limiting screentime is important to health.

Strongly Disagree (1)

Disagree (2)

Neutral (3)

Agree (4)

Strongly Agree (5)

Q219 q) Believe that snacking behavior is related to health.

Strongly Disagree (1)

Disagree (2)

Neutral (3)

Agree (4)

Strongly Agree (5)

Q220 To what degree do you agree or disagree with the following statements about
counseling parents?

Q221 a) I invite parents to talk about behavior change related to their child’s weight.

Strongly Disagree (1)

Disagree (2)

Neutral (3)

Agree (4)

Strongly Agree (5)

Q222 b) Parents perceive my sensitivity when talking about their child’s weight.

Strongly Disagree (1)

Disagree (2)

Neutral (3)

Agree (4)

Strongly Agree (5)
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Q223 c) I ask questions about what they think about their child’s weight.

Strongly Disagree (1)

Disagree (2)

Neutral (3)

Agree (4)

Strongly Agree (5)

Q224 d) I understand challenges that parents face in making changes in their child’s
weight-related behavior.

Strongly Disagree (1)

Disagree (2)

Neutral (3)

Agree (4)

Strongly Agree (5)

Q225 e) I provide information that is sensitive to their concerns.

Strongly Disagree (1)

Disagree (2)

Neutral (3)

Agree (4)

Strongly Agree (5)

Q226 f) I convey respect for their choices about behavior change.

Strongly Disagree (1)

Disagree (2)

Neutral (3)

Agree (4)

Strongly Agree (5)
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Q227 g) I feel comfortable talking to the parents about behavior change.

Strongly Disagree (1)

Disagree (2)

Neutral (3)

Agree (4)

Strongly Agree (5)

Q228 h) I understand the parent’s concerns about the HPV vaccine.

Strongly Disagree (1)

Disagree (2)

Neutral (3)

Agree (4)

Strongly Agree (5)

Q229 i) I feel comfortable talking to parents about the HPV vaccine.

Strongly Disagree (1)

Disagree (2)

Neutral (3)

Agree (4)

Strongly Agree (5)

Q230 To what degree do you agree with the following statements?

Q231 a) I know how to use Motivational Interviewing to help patients make behavioral
changes.

Strongly Disagree (1)

Disagree (2)

Agree (3)

Strongly Agree (4)
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Q232 b) I can easily incorporate Motivational Interviewing skills into my nursing
practice.

Strongly Disagree (1)

Disagree (2)

Agree (3)

Strongly Agree (4)

Q233 c) Motivational Interviewing will have an impact on my practice behavior.

Strongly Disagree (1)

Disagree (2)

Agree (3)

Strongly Agree (4)

Q234 d) I am likely to use motivational interviewing techniques when I counsel patients
and their families about weight.

Strongly Disagree (1)

Disagree (2)

Agree (3)

Strongly Agree (4)

Q235 e) Motivational Interviewing takes too much time.

Strongly Disagree (1)

Disagree (2)

Agree (3)

Strongly Agree (4)

Q236 f) Motivational Interviewing is a valuable tool to us in my practice.

Strongly Disagree (1)

Disagree (2)

Agree (3)

Strongly Agree (4)
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Q237 g) I would like to get more training in motivational interviewing techniques for
counseling patients and their families about healthy eating and activity behaviors.

Strongly Disagree (1)

Disagree (2)

Agree (3)

Strongly Agree (4)
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UTHSC CPHS Approval

NOTICE OF APPROVAL TO IMPLEMENT REQUESTED CHANGES
HSC-SN-15-0091 - Efficacy Trial of a Brief Parent-Based Adolescent Sexual Health
Intervention
PI: Dr. Diane Santa Maria
Reference Number: 172738
PROVISIONS: Unless otherwise noted, this approval relates to the research to be
conducted under the above referenced title and/or to any associated materials considered
at this meeting, e.g. study documents, informed consent, etc.
APPROVED: By Expedited Review and Approval
CHANGE APPROVED: Addition of Ashley Hollins to study team
APPROVAL DATE:
06/22/2018

CHAIRPERSON:
Rebecca Lunstroth, JD
Upon receipt of this letter, and subject to any provisions noted above, you may now
implement the changes approved at this meeting.
CHANGES: The principal investigator (PI) must receive approval from the CPHS
before initiating any changes, including those required by the sponsor, which would
affect human subjects, e.g. changes in methods or procedures, numbers or kinds of human
subjects, or revisions to the informed consent document or procedures. The addition of
co-investigators must also receive approval from the CPHS. ALL PROTOCOL
REVISIONS MUST BE SUBMITTED TO THE SPONSOR OF THE RESEARCH.
INFORMED CONSENT: Informed consent must be obtained by the PI or designee(s),
using the format and procedures approved by the CPHS. The PI is responsible to instruct
the designee in the methods approved by the CPHS for the consent process. The
individual obtaining informed consent must also sign the consent document. Please note
that if revisions to the informed consent form were made and approved, then old
blank copies of the ICF MUST be destroyed. Only copies of the appropriately
dated, stamped approved informed consent form can be used when obtaining
consent.
UNANTICIPATED RISK OR HARM, OR ADVERSE DRUG REACTIONS: The
PI will
immediately inform the CPHS of any unanticipated problems involving risks to subjects
or others, of any serious harm to subjects, and of any adverse drug reactions.
RECORDS: The PI will maintain adequate records, including signed consent documents
if required, in a manner that ensures subject confidentiality.
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